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 The exponential increase in nanomaterials (NMs) production and application has 
triggered concerns on the potential effect of these NMs to human health. This concern is not 
unwarranted as NMs, due to their small size, could persist in tissues. Moreover, their small 
size allows them to interact with cells or any other biological entities in the human body. 
Efforts to identify this potential interaction between NMs and any biological entities have 
been made, nevertheless most studies are dedicated on the human major organs such as lung 
and kidney but not the blood vessel network despite its pervasive critical function in human 
body. They act as conduits for the blood cells, nutrients, hormones and wastes circulation in 
and out of the human body. These pervasive conduits are known to be lined with a single cell 
layer of endothelial cells which regulate the solute exchange between the blood stream and 
the surrounding tissue. This makes endothelial cells to be the most likely cells that encounter 
the NMs circulating in human body. Undoubtedly, there is a need to investigate the 
interaction that occurs between endothelial cells and the NMs. Thus far, most research has 
been dedicated on the NMs’ cytotoxicity and inflammation inducement on endothelial cells. 
However, little work with the emphasis on understanding the interaction that manifest on 
function impairment of the endothelial cell barrier has been done. 
 This study aims to elucidate the interaction between NMs and endothelial cells with 
the emphasis on the mechanism which leads to the impairment of the endothelial cell barrier. 
This novel interaction was studied by employing human microvascular endothelial cells 
(HMVECs) and titanium dioxide nanoparticles (TiO2-NPs) as endothelial cells and NMs 
models, respectively. It is observed that TiO2-NPs, but not their microparticles counterpart, 
could induce intercellular gaps between adjoining endothelial cells. This phenomenon was 
coined as nanomaterials induced endothelial cells leakiness (NanoEL). NanoEL could be 
triggered in dose dependent manner within a short exposure time of 30 minutes. NanoEL was 
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observed to be independent from the known nanotoxicity events such as apoptosis and 
oxidative stress. From our NMs tracking analysis, NanoEL was observed to be activated 
through some extracellular trigger, as evidenced by the majority of the TiO2-NPs which had 
not been endocytosed by the cells at the onset of NanoEL.  
 A mechanistic study was conducted in order to understand how NanoEL was 
triggered. It was found that the NanoEL was initiated by the physical interaction of TiO2-NPs 
with endothelial cells adherens junction (AJ) protein, VE-cadherin, which is responsible to 
maintain the integrity of endothelial cells barrier. This led to the disruption of VE-cadherin 
homophilic interactions and activated an aberrant downstream signal transduction. It was 
found that the VE-cadherin lost its interaction with its anchoring proteins, β-catenin and 
p120, leading to its endocytosis and degradation. In addition, cell cytoskeleton rearrangement 
process was activated, which led to cell retraction and eventually brought about NanoEL. 
 The in vitro findings of NanoEL effect triggered by TiO2-NPs were validated by the 
in vivo study. It was observed that subcutaneous injection of TiO2-NPs could cause leakiness 
in the surrounding subcutaneous blood vessels in mice. In addition, TiO2-NPs induced blood 
vessel leakiness promoted the melanoma-to-lung metastasis both in acute and sub-chronic 
exposure scenario.  
 Overall, the study’s findings have revealed a new NMs’ toxic effect that is apparently 
non-cytotoxic but profoundly changes the normal functioning of endothelial cells. Most 
importantly, this study uncovers a novel non-receptor mediated mechanism which allows 
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 Nanotechnology, with its capability to produce precise nano-sized materials, has 
influenced human life tremendously. For example, in biomedical field NMs were deliberately 
introduced to detect and treat human diseases (Brigger et al., 2002; Jain and Stylianopoulos, 
2010). Yet the biggest NM utilization is in consumer products (PEN, 2011; Setyawati et al., 
2013a). The increase of human exposure to NMs, either deliberately or unintentionally, has 
incited many to question the safety of these NMs. This has subsequently prompted the 
investigation of these NMs interaction with human cells. Much progress has been made in 
studying the interaction of these NMs with various human cell models, manifested in 
traditional toxicity readouts like cell death, DNA damage and oxidative stress (Tay et al., 
2014b; Wu et al., 2012; Zhao et al., 2013). However, among the vast collective knowledge of 
nano-induced toxicity, only a few offers understanding of the interaction NMs with 
endothelial cells of the blood vessel.  
 The understanding of endothelial cell interaction with NM is pivotal due to the 
following reasons. First, the pervasive blood vessel networks in human body are the main 
conduits for compound distribution. Intravascular injection, despite all its downside is still the 
most preferable route of introduction for many nanomedicine (Howard et al., 2014). In 
addition, NMs in consumer products could unintentionally enter the human body through 
inhalation and ingestion, get distributed through the blood circulation and finally accumulate 
in various major organs (Davis et al., 2010; Hagens et al., 2007). The role of blood vessels as 
conduits to circulate many compounds, including NMs makes endothelial cells, which form 
the inner lining (Alberts et al., 2002), to be the most likely cells to encountered by and 
interact with the circulating NMs. Moreover, endothelial cells hold an important role of 
forming a barrier that regulates the exchange between the blood stream and the surrounding 
tissue (Alberts et al., 2002; Dejana, 2004). Given the importance of its function, endothelial 




cell barrier integrity is regulated tightly and the impairment of this barrier has been 
implicated in many known pathophysiological conditions such as metastatic tumor 
development, hypertension and atherosclerosis (Cai and Harrison, 2000). Considering the 
importance of the endothelial cell barrier function and the high probability of its interaction 
with NMs, it is then vital to understand the nature of the interaction between NMs and 
endothelial cells. Understanding the nature of this interaction is important not only to give a 
holistic view of current NMs design but also to enable the design of safer NMs in the future.  
 TiO2-NPs were employed as model NMs to study the interaction of NMs with 
endothelial cells. TiO2-NPs were chosen in this study due to their high utilization in the 
biomedical field as well as their prevalent application in many consumer products (PEN, 
2011; Setyawati et al., 2013a; Yin et al., 2013). Compared to other metal or metal oxide 
materials such as silver and zinc oxide, TiO2-NPs are relatively non-cytotoxic (Setyawati et 
al., 2013a), allowing us to gauge subtle interactions between NPs and endothelial cells, which 
are normally obscured under more pronounced cytotoxicity readouts.  
  
1.2. Hypothesis and Objectives 
  It is hypothesized that NMs circulating in the blood circulation interact with the 
endothelial cells that line the blood vessel and exert damaging effect to the endothelial cells 
which is manifested in the functional impairment of the endothelial cells barrier.  This study 
aims to investigate the said interaction between NMs and endothelial cells with the emphasis 
on the functional impairment of the endothelial cell barrier. In addition, this study aims to 
elucidate the mechanism behind the observed functional impairment and validate the findings 
in the animal model. This interaction was studied by employing HMVECs and TiO2-NPs as 
models for endothelial cells and NMs, respectively.  
 





 This thesis consists of seven chapters. Following this chapter, the literature review 
(Chapter 2) sums up the latest findings of TiO2-NPs applications, potential release and 
exposure to human. In addition, the known interaction between TiO2-NPs with human cells in 
general and their interaction with endothelial cells in particular are described. Chapter 3 
comprises of the experimental methodologies, approaches and analyses employed in this 
study. Chapter 4 shows the evidences of the disruption in the endothelial cell barrier as a 
damage arising from TiO2-NPs interaction with endothelial cells. Chapter 5 describes the 
mechanistic study to understand the interaction between TiO2-NPs and endothelial cells. 
Chapter 6 contains the in vivo validation of the effect of TiO2-NPs interaction with 
endothelial cells. Lastly, Chapter 7 summarizes overall findings followed by the future 
outlook from this thesis.  














 This chapter presents the literature review pertinent to studies on the interaction 
between TiO2-NPs and endothelial cells, particularly on the manifestation of endothelial cell 
monolayer permeability as the outcome. Studies that highlight the prevalence of TiO2-NPs in 
biomedical field and consumer products and the possible entry routes of TiO2-NPs into the 
human body are reviewed. In addition, studies that support NMs deposition in various major 
organs and NMs induction of increased endothelial cell barrier permeability are discussed to 
highlight the rationale of the present study.  
 
2.1. Nanoparticles 
Human life has rapidly progressed beyond imagination within the space of a few 
decades. One of the recognized powers behind this rapid progress is the technological 
prowess to manipulate materials on small dimensions. The science that allows this capability 
to take place is known as nanotechnology.  The Greek term “nano”, meaning “dwarf”, 
denotes one billionth meter, reflecting the object of minute proportions under the purview of 
this technology, the nanoparticles (NPs) (Joachim, 2005). These NPs are highly attractive due 
to their enhanced physicochemical properties which have never been witnessed before in 
their bulk counterpart (Johnston et al., 2009). Taking full advantage of their enhanced 
properties, NPs have been utilized in many fields, ranging from cutting edge applications in 
electronics (Konstantatos and Sargent, 2010), drug delivery (Brigger et al., 2002; Irvine, 
2011) and over-the counter consumer products and household wares (Figure 2.1) (Augustin 




























Figure 2.1: Pervasive use of NPs in modern lifestyle products. Reproduced with 
permission from (Setyawati et al., 2013a). Copyright 2013, WILEY-VCH Verlag GmbH & 
Co. KGaA, Weinheim. 
 
It is necessary to note that in this thesis, the term NPs refers specifically to engineered 
NPs synthesized in a controlled setting, as opposed to the free generation of NPs in 
environment (e.g. carbon particulates generated from engine combustion). 
 
2.1.1. Physical and chemical properties of TiO2-NPs 
Titanium is the ninth most abundant element in the earth’s crust. Titanium (Ti) does not 
naturally exist in its metallic state, due to its great affinity to oxygen and hydrogen. One of 
the most common natural forms of Ti is titania, better known as titanium dioxide (TiO2). 
TiO2 is mostly found in the form of a white, odorless, noncombustible powder. It possess a 
molecular weight of 79.9 g/mol, boiling point of 2972°C, melting point 1843°C and relative 
density of 4.26 g/cm
2
 (Shi et al., 2013). In contrast, TiO2-NPs are not present naturally on 




earth, but synthesized to arrive at their nano dimension. To date, chemical vapor disposition 
(CVD) and flame hydrolysis methods are widely used to produce TiO2-NPs. Using CVD, a 
volatile mixture (typically of titanium tetra-isopropoxide and argon) is converted to a 
nonvolatile solid and deposited on a substrate. The volatile compound is generated by many 
methods such as plasma, high temperature, and pressure (Li et al., 2003). In flame hydrolysis, 
an inert gas carries TiCl4 into a flame and produces HCl as well as various sizes of TiO2-NPs 
with high purity. This flame hydrolysis method was reported to produce Aeroxide P25 TiO2-
NPs, which is used as the model NM in this study (Mulenweg, 2004).  
TiO2 naturally exists in three crystal forms: rutile, anatase, and brokite. However, TiO2-
NPs reactivity is mainly affected by their minute size rather than their crystallinity. Lin et al. 
(2006) have shown that the decrease of particle size of TiO2 to approximately 29 nm resulted 
in the decrease of the band gap of the material. This decrease in the TiO2 band gap led to 
enhanced photocatalytic performance, as smaller band gap allows the material to utilize lower 
energy photons more efficiently than materials with bigger band gap (Lin et al., 2006). 
Moreover, the smaller the particle size, the higher surface area available for photon 
absorption and catalytic reaction, further enhancing TiO2-NPs reactivity (Li et al., 2012). This 
reactivity of TiO2-NPs can be witnessed in their capability to photocatalyze the formation of 
reactive oxygen species (ROS) on the surface. Incident light that carry photons with energy 
higher than the band gap will be absorbed by the TiO2-NPs and used to promote electron (e
‒
) 
movement from the valence band to the conduction band. Holes (h
+
) are created on the 
valence band that is left behind by the excited electrons (Li et al., 2012). The electrons in the 
conduction band show high reducing power, reducing oxygen to produce superoxide anion 
(O2
●‒
) (Li et al., 2012). In contrast, the holes in the valence band exhibit great oxidizing 
power against adsorbed hydroxyl ions to generate hydroxyl radicals (
●
OH) (Li et al., 2012). 
In aqueous environment, these radical species could evolve to other type of radicals such as 




hydrogen peroxide and peroxy radicals. The major reaction of reactive oxygen species (ROS) 
formation could be seen as follows:  




           (1) 
H2O + h









●      
(4) 
2 H2O
● → H2O2 + O2       (5) 
H2O2 + O2
●‒
 → ●OH+ OH‒ + O2       (6) 
 
2.1.2. Applications of TiO2-NPs 
Predictably, the enhanced physical and chemical properties of TiO2-NPs when compared to 
their bulk particle counterpart are notable to many technology developers. To date, more 
TiO2-NPs have been used to produce high value commercial products leading to high demand 
of TiO2-NPs production. In 2005, the annual TiO2-NPs global production was estimated to be 
close to 2,000 MT with total market value of USD 70 million (Dransfield, 2005). The annual 
TiO2-NPs global production has increased since then, reaching 10,000 MT/year in 2011 
(Davis et al., 2010) and was projected to increase exponentially and reach the level of 2.5 
million MT/year by 2025 in the U.S. alone (Figure 2.2) (Robichaud et al., 2009).   
 Most of the TiO2-NPs being produced ends up in various kinds of consumer products 
as white pigment. Many food products, like gum, icing, cookies, and candies utilize the TiO2-
NPs for its white pigment (Chaudhry et al., 2008; Scotter, 2011; Smolander and Chaudhry, 
2010). In addition, TiO2-NPs are employed to whiten skim milk (Shi et al., 2013). In recent 
publications, 20 food products, like chewing gum, candy, pastry and chocolate were found to 
contain 0.1- 12 µg of Ti per mg of tested food products (Peters et al., 2014; Weir et al., 2012), 
suggesting the presence of TiO2-NPs in these food products. Further size analysis showed 




that these food products contain TiO2 particles in the range of 30-400 nm, with more than one 
third having sizes less than 100 nm (Weir et al., 2012). 
 
 
Figure 2.2: Forecast of TiO2-NPs production in U. S. The forecast suggest exponential 
increase of TiO2-NPs production due to their high demand in the industrial sector. MT = 
Metric tons. Reproduced with permission from (Zhang et al., 2012). Copyright 2012, Elsevier 
B.V. 
  
 Moreover, TiO2-NPs are also added in food-contact materials, namely in the polymer-
based food packaging and glass and metal used in food processing. Owing to its capability to 
absorb UV light, TiO2-NPs are incorporated to polymers film to enhance the light-barrier 
properties and prevent photo degradation of many food-packaging materials (Chaudhry and 
Groves, 2010; Chaudhry et al., 2008). Another benefit for adding TiO2-NPs to food 
packaging are derived from their excellent photocatalytic property. UV-activated TiO2-NPs 
have been used to inactivate E. coli and Salmonella (Kim et al., 2003; Kim et al., 2009), 
providing antimicrobial protection necessary to increase the quality and the shelf life of the 
food (Díaz-Visurraga et al., 2010; Smolander and Chaudhry, 2010). Likewise, biofilm growth 
could be prevented with application of TiO2-NPs on the steel and glass surfaces used in the 
food processing step (Chorianopoulos et al., 2011). 
 In addition to the food industry, TiO2-NPs are widely applied as white pigment in 
personal care products and cosmetics, with utilization in sunscreen products ranks as the 




highest among the others. The popularity of TiO2-NPs in sunscreen products due to several 
reasons, namely their enhanced properties to absorb UVB (290-320 nm) while scatter UVA 
(320-400 nm). This means the TiO2-NPs containing sunscreen could lend higher sun 
protection factor (SPF) when compared to those utilizing the larger TiO2 microparticles (Lin 
and Lin, 2011). Furthermore, TiO2-NPs scatter very little visible light, thus allowing a 
transparent layer when applied on skin. This leads to greater consumer acceptance and 
increased popularity of the NPs-based sunscreen products (Davis et al., 2010; Shao and 
Schlossman, 1999). The popularity of TiO2-NPs utilization in sunscreen was well 
documented in a recent publication by Weir et al. (2012), which showed the presence of 14 - 
90 µg TiO2 per mg of sunscreen in 13 types of sunscreens. To date, an extensive list of 
personal care products such as deodorants, toothpastes, shaving creams, anti-wrinkle creams, 
moisturizers, foundations and face powders has been known to incorporate TiO2-NPs. It has 
been estimated that the TiO2-NPs concentration in these products range from 0.1 to 0.5% 
weight (Mulenweg, 2004; Weir et al., 2012). Additionally, TiO2-NPs are used to coat over 
the counter medication such as low-dose aspirin products (81 mg aspirin dose). Zachariadis 
and Sahanidou (2011) reported the TiO2-NPs content in aspirin product to be as high as 0.014 
µg of TiO2/mg aspirin. A validation study done by Weir et al. (2012) found that safety coated 
aspirin contains 0.017 – 10 µg of TiO2 /mg of aspirin.  
Due to their enhanced catalytic properties, TiO2-NPs are also used to treat waste water 
which contaminated with hazardous industrial waste, arsenics. Photocatalytic action of TiO2-
NPs converts the arsenite (As
III
) to arsenate (As
V
), which is insoluble in water, allowing ease 
of removal from waste water (Dutta et al., 2005; Ferguson et al., 2005; Pena et al., 2006). 
Other utilization of TiO2-NPs photocatalytic properties in consumer products could be found 
in self-cleaning tiles, self-cleaning windows, self-cleaning textiles, and anti-fogging window 
(Shi et al., 2013). 




In the medical field, TiO2 has long been used as one of the base materials for 
orthopedic implants (Jacobs et al., 1991; Shi et al., 2013). However, recent studies suggest 
more diversified applications of TiO2-NPs in the medical field. Taking advantage of its 
photocatalytic capability, TiO2-NPs were explored to be used as a photosensitizer for 
photodynamic therapy against cancer cells. To date, a long list of human cancer cells, 
including cervical cancer (HeLa), bladder cancer (T24), monocytic leukima (U937), colon 
carcinoma (Ls-147-t), breast cancer (MCF-7 and MDA-MB-468), and hepatoma (Bel 7402), 
have been reported to respond well to the TiO2-NPs photodynamic treatment (Cai et al., 
1992; Lagopati et al., 2010; Wang et al., 2011; Yin et al., 2013; Zhang and Sun, 2004). In 
addition, TiO2-NPs with various shapes and sizes were fabricated to carry and deliver drugs   
to cancer cells (Yin et al., 2013). For example, Qin et al. (2011) utilized TiO2-NPs to deliver 
doxorubicin to C6 glioma cells. Similarly, Li et al. (2009) used one dimensional TiO2 nano 
whiskers to enhance the uptake of anti-tumor daunorobucin in hepatocarcinoma cells 
(SMMC-7221), resulting in the overall efficacy of anti-tumor treatment. 
The high utilization and diverse applications of TiO2-NPs will undoubtedly increase 
human exposure and potential health risks. The next section is dedicated to discuss the 
possible release of TiO2-NPs throughout their lifecycle to better understand potential human 
exposure to TiO2-NPs. 
 
2.2. TiO2-NPs and human exposure: potential TiO2-NPs release throughout their life 
cycle  
The effort to understand the potential effect of TiO2-NPs on human life starts with 
identifying the potential release of TiO2-NPs throughout their life cycle. Clear identification 
of the TiO2-NPs release profile will allow assessment of the extent of human and 
environmental exposure to TiO2-NPs. Figure 2.3 depicted the possible human exposure 




within the duration of TiO2-NPs life cycle, starting from their synthesis, application to their 
disposal is depicted in. Workers at TiO2-NPs production factories encounter the highest risks 
of exposure during the handling, transferring, bagging, and mixing of the TiO2-NPs. Lee et 
al. (2011) monitored occupational exposures in TiO2-NPs manufacturing facilities in Korea 
and found that the concentration of TiO2-NPs in the air to be in the range of 0.1 - 4.99 
mg/cm
3
. Conversion of this gravimetric concentration gave disconcerting particle number 




the particles size of 15 - 710 nm (Lee et 
al., 2011).  
 
 
Figure 2.3: Potential human exposure to TiO2-NPs. Each stage on the life cycle of TiO2-
NPs, from their synthesis, application to disposal, brings about possibility of their release to 
their immediate surroundings. Synthesis of TiO2-NPs leads to potential occupational hazard. 
Whereas, the wide application of nanomaterials leads to public exposure and its disposal may 
possibly cause the ecological exposure. Reproduced with permission from (Setyawati et al., 
2013a). Copyright 2013, WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
 
For the general population, it is believed that public exposure comes about from the 
application of TiO2-NPs in many consumer products, with the main exposure route through 




consumption of food products containing TiO2-NPs as additive. It has been estimated that 
human daily intake of TiO2, which contains 30% of particles in the nanoscale, from food 
alone to be in the range of 15-37.5 mg for a 75 kg male adult (Brun et al., 2014; Weir et al., 
2012).  Secondary exposure routes could come about by way of NPs leaching out from the 
food-contact materials into food. Additionally, accidental oral exposure through use of oral 
hygiene products and consumption of medical products with TiO2-NPs is considered as one 
of the alternative route for the NPs to enter public domain (Davis et al., 2010; Weir et al., 
2012).  Moreover, orthopedic implants are known to occasionally undergo degradation, 
exposing the patient with TiO2-NPs (Jacobs et al., 1991). Unintended exposure of TiO2-NPs 
aside, the limited few in the general population could also be exposed to TiO2-NPs through 
the intentional introduction of nanomedicine (Howard et al., 2014).  
In addition, TiO2-NPs could enter the environment via several routes and lead to 
ecological exposure. Most of ecological exposure to TiO2-NPs is caused by disposal of TiO2-
NPs laden products. Personal care products could release the TiO2-NPs into the water ways 
through bathing and laundry. Davis et al. (2010) recounted that topical sunscreen constituents 
could be detected in various bodies of water including untreated waste water, treated waste 
water and surface water (lakes and rivers). The presence of TiO2-NPs in treated waste water 
highlights the inefficiency of TiO2-NPs removal during the water treatment process. Zhang et 
al. (2008) observed that approximately 20% of the initial TiO2-NPs (10 mg/L) still remain in 
waste water even after the processes of coagulation, flocculation and sedimentation. 
Moreover, almost half of the population of the remaining TiO2 particles was found to be 
smaller than 500 nm in size (Zhang et al., 2008). The TiO2-NPs escaping from the water 
treatment process may eventually enter the downstream water ways including potable water 
sources (Bystrzejewska-Piotrowska et al., 2009).  




The extent of TiO2-NPs ecological exposure is so far-flung to include the presence of 
TiO2-NPs in the air and soil. It was reported that TiO2-NPs release are not limited to 
manufacturing facilities but include the immediate ambient atmosphere. Airborne TiO2-NPs 
outside of a European TiO2-NPs production facility, which is known to supply the requisite 
NPs for sunscreen and cosmetics (Berges, 2007). Airborne TiO2-NPs found outside of the 
plant was approximately 13,000 particle/cm
3
, wherein nearly 94% of the particles are 100 nm 
or less in size. Through a modelling study, Gottschalk et al. (2009) estimated the TiO2-NPs 
content in U.S. soil to be 0.6 mg/kg. Additionally, the authors predicted the increase of TiO2-
NPs concentration in sludge-treated soil from 0.1 mg/kg in 2008 to 0.5 mg/kg in 2012 
(Gottschalk et al., 2009).  
Extensive ecological exposure could lead to TiO2-NPs entering the food chain and 
further exposing the public with contaminated food sources. Davis et al. (2010) reported that 
TiO2-NPs could also be found in the fish living in the contaminated lakes and rivers. Zhang et 
al. (2006) observed the bioaccumulation of TiO2-NPs in carp tissues such as the visceral 
organs, gills, skin, scales and muscle. It has also been noticed that vegetable crops were able 
to absorb TiO2-NPs from contaminated soil. TiO2-NPs absorbed by field mustard and lettuce 
amounted to the level of 4 - 10 mg Ti/kg plant weight (Song et al., 2013). The amount of 
absorbed TiO2-NPs reached the level of 12.85 mg Ti/kg plant weight when hydroponic 
system was used (Song et al., 2013). Much higher TiO2-NPs absorption was observed on 
wheat crop, where TiO2-NPs with size less than 140 nm accumulated in the wheat roots with 
concentration of 109 mg Ti/kg dry weight of the plants. TiO2-NPs with size smaller than 36 
nm could even be found in the wheat leaves (Larue et al., 2012).  
In summary, humans could be exposed to TiO2-NPs in various stage of the NPs life 
cycle. Occupational exposure to the NPs occurs during the production and distribution of the 




NPs, while a much larger exposure scale of the NPs to the public and the environment occurs 
during the NPs’ application and disposal. 
 
2.3. TiO2-NPs and human exposure: uptake route and distribution in human body 
Exposure entails more than just detecting TiO2-NPs presence in the environment, as 
actual contact and entry into the human body must occur. Evidences in the preceding section 
suggest that TiO2-NPs in the soil and water could be absorbed by plants. To date, there is no 
direct evidence yet to show that the human body could absorb the TiO2-NPs. Nevertheless, a 
seminal study conducted by Schroeder et al. (1963) reported that the human body takes in and 
accumulates bulk titania particles from the environment (e.g. water, air, and food stock). This 
suggests some TiO2-NPs absorption into human body could occur with the extensive use of 
these NPs. This section is dedicated to discuss the points of entry of the TiO2-NPs into human 
body and more importantly the fate of these NPs in human body. Figure 2.4 illustrates the 
possible entry routes of TiO2-NPs into human body and theirs potential fate in the human 










Figure 2.4: Possible entry route and translocation of TiO2-NPs in human body. Once 
taken in, TiO2-NPs could be systematically distributed to any major organ in the human body 
through the blood stream. Black lines represent conﬁrmed routes of NPs distribution; dashed 
lines represent hypothetical routes. Reproduced with permission from (Hagens et al., 2007). 
Copyright 2007, Elsevier B.V. 
 




2.3.1. Inhalation of TiO2-NPs  
Inhalation is deemed to be the main route for TiO2-NPs to enter the human body. 
Workers in the manufacturing factories could inhale powdered TiO2-NPs. The general public 
could inhale the aerosol from spray-based sunscreen products in addition to water aerosol 
containing TiO2-NPs while showering. Due to its small dimension, TiO2-NPs could penetrate 
deep into the lungs and reach the highly vascularized lung alveoli regions. Through a 
modeling study, Oberdorster et al. (2005) predicted size dependent deposition of inhaled NPs 
in human lung regions (Figure 2.5). NPs with size of 1 nm are predominantly deposited in 
the nasopharyngeal (nasal, pharyngeal and laryngeal) region. In contrast, 5 nm NPs are 
distributed equally in the nasopharyngeal region, tracheobronchial region and alveolar region.  
More than 50% of the 20 nm NPs could be found in the alveolar region, while regions of 
nasopharyngeal and tracheobronchial receive equal deposition of 15% (Oberdorster et al., 
2005). 
 
Figure 2.5: Predicted inhaled nanoparticle distribution in the human lung. Inhaled NPs 
could potentially deposit on the three sites of the human respiratory tract: nasopharyngeal 
region (blue), tracheobronchial region (green), and alveolar region (orange). Reproduced with 
permission from Oberdorster et al. (2005). Copyright 2005, Environmental Health 
Perspective. 
 




Unlike bigger particles, deeper penetration into the lung regions precludes these NPs 
from clearance in the upper airway mucociliary system thus resulting in longer retention in 
human body (Hagens et al., 2007; Oberdorster et al., 2005).  In a 12 weeks inhalation study, 
rats exposed to TiO2-NPs with 20 nm size were observed to have longer retention time of 501 
days in their lungs as opposed to those exposed to larger TiO2 fine particles (250 nm) that 
showed only 174 days retention time (Oberdorster et al., 1994).  
 
2.3.2. Ingestion of TiO2-NPs  
The human digestive system is a 9 meter long tract, which makes this tract the main 
entrance site for TiO2-NPs found in food products, water and nanomedicine. The absorption 
of TiO2-NPs is considered to occur in the small intestine and colon where the food substance 
is mostly absorbed. Brun et al. (2014), both in their in vivo and ex vivo mouse model, 
detected the presence of TiO2-NPs in the mouse gut upon 6 hour single oral gavage with the 
dose of 12.5 mg/kg body weight (BW). Similarly, other study conducted by Wang et al. 
(2007a) observed the absorption of TiO2-NPs applied in a single oral dose of 5g/kg BW to be 
absorbed by the gastrointestinal tract. The authors further suggested that the gastrointestinal 
absorption of NPs is facilitated by the Peyer’s patches, as evidenced by the high occurrence 
of TiO2-NPs detected in the lymphoid tissue (Geraets et al., 2014; Wang et al., 2007a). 
In more recent studies, the upper digestive system such as the buccal mucosa in the oral 
cavity is reported to be able to absorb TiO2-NPs. Tay et al. (2014b) observed that human oral 
mucosa cells (TR146) take up the TiO2-NPs readily. Similarly, ex vivo model of pig buccal 
mucosa show high absorption of these NPs (Teubl et al., 2014). This suggests that the 
digestive tract could also act as point of entry for TiO2-NPs in the consumer care products, 
especially those used in oral hygiene. 
 




2.3.3. Dermal penetration of  TiO2-NPs  
The skin is the largest possible organ in our body exposed to TiO2-NPs. Skin is mainly 
exposed to TiO2-NPs through sunscreen. One sunscreen application was estimated to 
introduce TiO2-NPs be in the range of 12 - 55 mg/kg BW for a toddler and 8 – 37 mg/kg BW 
for an adult (Davis et al., 2010). High exposure in young children could be noteworthy in 
relation to indication that skin of infants and young children might have less barrier function 
than mature skin. Taking consideration on the high TiO2-NPs exposure on skin, many groups 
have dedicated themselves to study the possible penetration of TiO2-NPs. Mavon et al. (2007) 
studied the distribution of TiO2-NPs (20 nm) five hours  following  topical application of the 
NPs.  Their findings showed that majority of TiO2-NPs did not pass through the stratum 
corneum and only distributed minimally in the epidermis (Mavon et al., 2007). Change in the 
surface coating proves to have no effect on the dermal penetration of TiO2-NPs. Topical 
application of silica- and aluminum oxide-coated TiO2-NPs (10-100 nm) showed penetration 
limited to the stratum corneum (Schulz et al., 2002). Summarily, TiO2-NPs do not penetrate 
beyond the stratum corneum (hair follicles layer) and do not penetrate into living cells of 
healthy skin (Davis et al., 2010).  
Nevertheless, it is worthy to note that previously described studies were done on 
healthy human skin. To date there is no study which report skin penetration of TiO2-NPs in 
healthy flexed skin or on damaged skin, though there are ample case studies for other types of 
NPs. Increased fullerene penetration was reported in flexed porcine skin (Rouse et al., 2007) 
and quantum dots had higher degree of penetration on flexed and abraded rat skin (Zhang and 
Monteiro-Riviere, 2008) compared with healthy skin. Furthermore, the available TiO2-NPs 
penetration models failed to account the repeated exposure to TiO2-NPs. Recent study using 
pig and hairless mice models suggest that repeated dermal exposure could lead to deeper 
TiO2-NPs penetration into epidermis living cells as well as systemic distribution (Wu et al., 




2010b). Similar to previous studies, the authors observed no significant penetration beyond 
stratum corneum following 24 hour exposure of TiO2-NPs onto porcine skin. However, 30 
days in vivo exposures to TiO2-NPs on the ear skin of pigs resulted in deeper penetration that 
reached the epidermis. Sixty days of in vivo dermal exposure of hairless mice to 10-60 nm of 
TiO2-NPs showed the presence of TiO2-NPs in multiple organs including skin, subcutaneous 
muscle, heart, liver, and spleen (Wu et al., 2010b).  
 
2.3.4. Blood circulation as TiO2-NPs distribution route 
One notable commonality of the TiO2-NPs entering via the inhalation, ingestion and 
dermal penetration routes is that they are translocated to various organs distal to their entry. 
For instance, Wang et al. (2008) observed that inhaled TiO2-NPs with size of 80 nm and 155 
nm could translocate from the nasal cavity to brain. Following internasal instillation at 
concentration of 24 mg/kg BW applied every other day for the duration of 30 days, the 
authors noted that TiO2-NPs could be found in the hippocampus, central cortex, and 
cerebrum, in addition to olfactory bulb (Wang et al., 2008). Similarly, two weeks oral 
exposure to TiO2-NPs resulted in the wide distribution of the NPs in  liver, spleen, lungs, and 
kidneys of the mouse (Wang et al., 2007a). Likewise, Wu et al. (2010b) observed 
translocation of TiO2-NPs to multiple organs including skin, subcutaneous muscle, heart, 
liver, and spleen after topical application on hairless mice. Chen et al. (2009) observed TiO2-
NPs accumulation mostly in the spleen, lung, liver, kidney and in small degree the heart 14 
days following a single bolus intraperitoneal injection of TiO2-NPs into the mouse. 
Numerous other animal studies supported the evidence of TiO2-NPs translocation to organs at 
distal part of the body, including brain, lymph nodes, bone marrow, brain, spleen and heart 
(Davis et al., 2010; Ferin et al., 1992; Li et al., 2010). 




Translocation describes the NPs movement from the original site of absorption to 
another part of the body (Shi et al., 2013). The existing paradigm of NPs translocation could 
be described as the following. First, inhaled and ingested NPs are absorbed across the 
respiratory tract and the gastrointestinal tract, respectively. As the result of the absorption 
through these tracts, NPs could be introduced into the blood circulation by which they are 
carried over the whole body and get absorbed from the blood circulation into the various 
organs in the body (Ferin et al., 1992; Hagens et al., 2007; Oberdorster et al., 2005).  The role 
of blood circulation in TiO2-NPs distribution and translocation was confirmed with 
intravenous introduction of NPs. Fabian et al. (2008) observed systematic distribution 
following one bolus of intravenous TiO2-NPs injection (5 mg/kg BW) in the major organs of 
rats, namely liver, kidney, spleen, and lungs. Similarly, Umbreit et al. (2012) reported the 
accumulation of the TiO2-NPs in major filtration organs such as liver, lung, and spleen 
following direct injection of the NPs.  
 
2.3.5. Biopersistence and excretion of TiO2-NPs 
There are two possible excretion paths for TiO2-NPs which enter the human body: 
through kidney filtration and urine; and through biliary system and feces. A small degree of 
TiO2-NPs could be cleared away by the kidney, as observed by Cho et al. (2013) who found 
traces of unabsorbed TiO2-NPs in the urine 13 weeks after oral administration of the NPs. 
Clearance of unabsorbed NPs occurs mostly with the help of the liver through the biliary 
system. Ingested TiO2-NPs is known to be cleared primarily via the bile into the feces (Cho et 
al., 2013). In an in vivo study, TiO2-NPs which were not absorbed by the gastrointestinal tract 
were found in animal feces (Cho et al., 2013).  
Similarly, inhaled TiO2-NPs are cleared from the human body predominantly by way of 
biliary system. Due to inefficient lung clearance by macrophages and tendency for 




translocation, most of the NPs find their way to the gastrointestinal tract (Semmler et al., 
2004). From here, the NPs might be cleared through the biliary system despite not being 
ingested in the first place (Semmler et al., 2004; Shi et al., 2013).    
The greater challenge is posed by those TiO2-NPs which are absorbed and cannot be 
cleared away from the body. Due to their small size, these NPs could not be cleared by  
macrophages (Oberdorster et al., 1994). To make matters worse, these NPs are insoluble in 
nature and persist in organs indefinitely. Cho et al. (2013) observed the presence of the TiO2-
NPs in various vital organs 13 weeks post-exposure. The longest TiO2-NPs biopersistence 
case that is known was observed by Oberdorster and coworkers in the rat lung (Oberdorster et 
al., 1994). The authors found the NPs to persist in the organ for 501 days, which accounts for 
more than half the life span of a rat (Oberdorster et al., 1994).  
In summary, inhalation, ingestion, and dermal penetration could be considered as the 
entry points of TiO2-NPs in the context of occupational and environment exposure. In 
contrast, in the context of nanomedicine exposure, intravenous injection represents the 
predominant route of entry. Following the NPs entrance to the human body, they could be 
absorbed and distributed via the blood circulation to various distal organs in the body. 
Furthermore, once entering the human body, in many cases they could not be totally cleared 
out, resulting in the deposition of these NPs in major organs in the body and remain there for 
months or years.  
 
2.4. TiO2-NPs induced biological response 
The TiO2-NPs persistence in many vital major organs has prompted many to be 
concerned with its potential effect on the human body.  The concern is brought about by the 
fact that TiO2-NPs are synthesized on a matching scale with many of the cells’ biological 
machineries (Suh et al., 2009), making the interaction between the NPs and cells somewhat 




inevitable. Understanding how the NPs and cells interact becomes pivotal, as this interaction 
dictate how the cells response. Subsequently, cellular response directs the toxicity, pathology 
and other biological responses that could be observed in the organism. Thus, this section is 
dedicated to discuss the biological response elicited by the cells in response to TiO2-NPs. 
 
2.4.1. Cytotoxicity 
Cell death or cytotoxicity is the most common TiO2-NPs induced biological effect to be 
reported. This effect garners much attention due to the fact that death in the cellular level 
could potentially lead to systemic organ failure. TiO2-NPs induced cytotoxicity is the 
byproduct of its damaging interactions with cell organelles. Due to the abundance of possible 
interacting partners in the cell and the complexity of the interaction, the mechanism of TiO2-
NPs induced cytotoxicity could not be limited to one particular mechanism. Nevertheless, the 
bulk of studies available at the start of this study suggest that TiO2-NPs induced cytotoxicity 
center on the development of oxidative stress due to ROS production accumulation in cells.  
Due to the highly reactive nature of ROS, it is reported to be able to damage the cells 
walls by oxidizing the lipid bilayer components of the cell membrane such as cholesterol, 
linoleate and oleate. These highly oxidizable lipid substrates make the cell membrane a 
highly vulnerable target of ROS attack (Yin et al., 2011). Hussain et al. (2010) detected the 
lipid peroxidation caused by TiO2-NPs on human bronchial epithelial cells (16HBE14o) after 
only 1 hour of exposure to TiO2-NPs (Hussain et al., 2010). As a result of this peroxidation, 
the authors observed TiO2-NPs induced cell death. 
Another potential target of ROS attack is the mitochondria, which regulates 
intracellular aerobic energy production and electrolyte homeostasis (Cooper, 2000). Direct 
insult of ROS on the lipid bilayer will cause lipid peroxidation followed by pores formation 
on the mitochondrial membrane. Permeabilization of the mitochondrial membrane perturbs 




numerous cellular functions, leading to inhibition of oxidative phosphorylation, cellular 
bioenergetic deficits and eventually cell death (Cooper, 2000; Freyre-Fonseca et al., 2011). 
Furthermore, damaged mitochondria membrane may allow pro-apoptotic protein, cytochrome 
c,
 
to be released and bind to pro-caspase 9 to activate the chain of apoptotic events (Fadeel 
and Orrenius, 2005). In addition to the direct assault on the membrane itself, TiO2-NPs 
induced oxidative stress could impair mitochondrial function indirectly by disturbing electron 
flow, dissipating the mitochondrial membrane potential and causing irregular mitochondrial 
Ca
2+
 uptake. All of these lead to large-scale membrane pores opening and release of pro-
apoptotic proteins, followed by cell demise (Xia et al., 2006). 
 
2.4.2. Genotoxicity  
TiO2-NPs are found to cause DNA damage through the mediation of the cells oxidative 
stress. Spherical TiO2-NPs were reported to induce oxidative stress, which further led to 
further damages in form of single strand break and lesions in the DNA of human lung 
epithelial (A549) cells. Moreover the TiO2-NPs was reported to deactivate the cellular 
pathways of nucleotide excision repair (NER) and base excision repair (BER), rendering the 
cell incapable of repairing DNA damage (Jugan et al., 2012). Similarly, Bhattacharya et al. 
(2009) observed the formation of DNA adducts (8OHdG) in human lung fibroblast as effect 
of TiO2-NPs induced oxidative stress.  
The fate of the cells with DNA damage typically depends on the extent of the damage 
and their capability to cope with such damage. Human lymphocytes activated the p38/JNK 
pathway and caspase-8/Bid apoptosis pathway upon TiO2-NPs induced DNA damage (Kang 
et al., 2009). On the other hand, human lung epithelial (Beas2B) cells activated mitochondrial 
dependent apoptosis pathway as their response toward the DNA damage induced by TiO2-




NPs. Petković et al. (2011) and Kang et al. (2008b) reported the activation of p53 dependent 
apoptosis pathway in response to the genotoxic effect of TiO2-NPs. In contrast, human 
amnion epithelial cells (WISH) were able to halt their cell cycle progression at G2/M 
checkpoint in order to restrict the damaged genetic information to be inherited to the next 
generation of cells (Saquib et al., 2012). Likewise, in response to DNA damage in neuron 
cells, JNK pathway and p53 pathway were activated to stop cell proliferation at G2/M 
checkpoint (Wu et al., 2010a).   
 
2.4.3. Oxidative stress  
As mentioned earlier, TiO2-NPs induced biological responses mainly revolve around 
the oxidative stress in cells. Oxidative stress defines a condition where intracellular ROS is 
produced at an elevated level. How TiO2-NPs could induce such ROS production is largely 
unclear hitherto. In nanomedicine studies (Xiong et al., 2013; Yin et al., 2013) where the 
authors employed light to trigger the photocatalytic properties of TiO2-NPs, the mechanism 
of ROS production could be clearly ascribed to photon absorption from incident light, as has 
been discussed in section 2.1.1. Nevertheless, elevated ROS level could be detected inside 
cells despite lack of light exposure (Gurr et al., 2005; Tay et al., 2014b).  This suggests that 
TiO2-NPs could indirectly cause the production of intracellular ROS and the photocatalytic 
process is not the predominant mechanism at play in cellular oxidative stress induced by 
these NPs.  
ROS is one of the many products of cellular metabolism and respiration, which 
typically is kept at a homeostatic level by a host of anti-oxidative enzymes such as catalase, 
superoxide dismutase, and glutathione peroxidase (Finkel and Holbrook, 2000). Freyre-
Fonseca and coworkers (2011) observed that TiO2-NPs caused dysfunction in cellular 
respiration. The NPs were found to impair oxidative phosphorylation and restrict ADP 




consumption, which leads to the increase of anaerobic glycolysis and mitochondria 
impairment. The mitochondria damage led to the accumulation of ROS (Freyre-Fonseca et 
al., 2011).  Moreover, TiO2-NPs were observed to bind to catalase, one of the anti-oxidant 
enzymes responsible for controlling the ROS level. As a result of binding to TiO2-NPs, 
catalase lost its inherent structure and subsequently, its anti-oxidative activity (Zhang et al., 
2014). Notable decrease in anti-oxidative activities of glutathione (GSH) and catalase 
following TiO2-NPs treatment in WISH cells also has been reported by Saquib et al. (2012).  
The increase of intracellular ROS coupled with the cells inability to curb it down lead 
to oxidative stress, a condition where excessive amount of ROS present in the cells brings 
damage to the cellular organelles such as mitochondria, DNA, cell membrane and protein 




Figure 2.6: The threats of ROS in cells. Though essential for cell regulation, when left 
unchecked, ROS could damage cellular organelles such as the cell membrane, mitochondrial, 
DNA, and protein damage. Reproduced with permission from (Setyawati et al., 2013a). 
Copyright 2013, WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim. 
 
  




2.4.4. Correlation of physicochemical properties of TiO2-NPs and the elicited biological 
responses 
TiO2-NPs elicited biological response is greatly influenced by its physical properties 
such as: size, crystallinity and surface coating (Zhu et al., 2012). Size is considered as the 
main deciding factor for TiO2-NPs induced biological responses due to the fact that TiO2 NM 
possess higher surface area than the bulk counterpart when administered in equal mass 
(Johnston et al., 2009). The higher surface area of TiO2-NPs enables them to catalyze more 
ROS production.  
 The crystallinity of TiO2-NPs also contributes to their overall capability to induce 
biological response from the cells. TiO2-NPs with anatase crystal form was reported to be 
100 times more toxic when compared to equivalent mass of rutile form TiO2-NPs (Sayes et 
al., 2006). This is probably due to the fact that anatase TiO2-NPs have the capability to 
induce higher level of ROS production when compared to the rutile form of TiO2-NPs (Zhang 
et al., 2012).  
Lastly, TiO2-NPs toxicity profile is also dependent on its surface moieties. 
Hydrophobic TiO2-NPs (due to silane coating) were reported to elicit higher inflammatory 
response in rats when compared to the uncoated TiO2-NPs (Oberdorster, 2001). 
In summary, due to their small dimension, TiO2-NPs could interact with cell organelles 
and induce biological response due to its capability to induce the intracellular production of 
ROS. The elevated ROS level then causes the cells to undergo oxidative stress condition and 
potentially damage the cell organelles, which may lead to cell death. Table 2.1-2.8 tabulates 
the summary of TiO2-NPs induced biological response in different tissue models. 













lung epithelial cells 
Increased DNA damage 
Increased lipid peroxidation 
Increased oxidative stress 
Decreased cell viability 
Observed response only for 10 and 20 nm NPs 






No increase in cytotoxicity 
No ROS generation or inflammation observed 





Increased ROS production 
Decreased GSH 
Increased apoptosis 
Increased expression of oxidative stress genes  
(IL-1, IL-6, IL-8, TNF-α) 
(Park et al., 2008) 
21 
A549   
lung epithelial cells 
Increased cytotoxicity 
Increased ROS production 
Increased IL-8 production 
(Sayes et al., 2006) 
unknown A549 
Increase of IL-8 mRNA and protein levels 
GSH depletion with both TiO2 




Cytotoxicity effect only in IMR 90 
Dose dependent ROS production 




Cell viability unchanged 
Increase ROS production (for NPs) 
Activation of MAPK pathway 
(Kang et al., 2008a) 












Particle size (nm) Model Results Reference 
30 
BV2 
Brain microglia  
Rapid and sustain production of oxidative species 
Mitochondrial disruption 
(Long et al., 2006) 
< 25, 
1000-1300 
U87  astrocytoma cells 
HFF1 fibroblast cells 
Micro and nano TiO2 particles caused a reduction of cell 
viability in U87 and HFF1 cells 




Reduction in cell viability 
Increased apoptosis cells 
Increased ROS 
(Liu et al., 2010) 
21,  
1000 
BV2 cells  
with and without LPs 
stimulation 
TiO2-NPs increased LPS induced TNF-α 
TiO2-NPs augmented NF-B activity in LPs stimulated cells 
(Shin et al., 2010) 
Particle size (nm) Model Results Reference 
5.2 and 10.1 
HDF 
dermal fibroblast 
Dose and time dependent cytotoxicity 
Increased LDH release 
Decrease mitochondrial activity 
Increase ROS production 
(Sayes et al., 2006) 
5 
CCL-110  
normal skin fibroblast 
Decrease cell stiffness in the presence of TiO2-NPs and UVA, 
UVC  
(Vileno et al., 2007) 
4, 10, 21, 25, 60 HaCaT 
Dose dependent cytotoxicity 
Induced oxidative stress 
(Xue et al., 2010) 
21 BJ skin fibroblast Increase genotoxicity and cytotoxicity (Setyawati et al., 2013b) 
20 -100  L929 skin fibroblast 
Decreased cell viability 
Increased ROS production 
Decreased GSH and SOD 
(Jin et al., 2008) 




Table 2.4: Selected publications on TiO2-NPs induced biological responses in the gastrointestinal model.  
 
 












Increase apoptosis cells 
Increase ROS production 
Increase inflammatory genes expression (IL6, IL1, TNF-α) 
(Tay et al., 2014b) 
21.2 
Ls-174-t 
colon carcinoma cells 
Reduction of cell viability after UVA irradiation. 
No cytotoxicity from non-irradiated TiO2 NPs 
(Zhang and Sun, 2004) 
< 40 
Caco-2 
colon carcinoma cells 
Minimum cytotoxicity   
Increased of intracellular calcium ions 
(Koeneman et al., 2010) 










Increased gene expression of DNA damage pathway 




Loss in mitochondrial membrane potential 
Increased in apoptosis cells 
Increased protein expression of p53, Bax, Bcl-2, Hsp70, Hsp60, 
caspase-9,  caspase-3, and Cytochrome c 
(Shukla et al., 2013) 


















Particle size (nm) Model Results Reference 
13-35 
HEK-293 
embryonic kidney cells 
Increased cell mortality 
Increased oxidative stress 
Increased apoptosis cells 
Increased expression of p53, Bax, caspase-3 
(Meena et al., 2012) 
12 
IP15 
glomerular mesangial cells 
HK-2 
proximal tubular cells 
Minimum cell mortality 
Increased ROS production 
(Pujalte et al., 2011) 
Particle size (nm) Model Results Reference 
70 
HDMEC 
dermal microvascular  
endothelial cells 
No cytotoxicity 
No effect on cell proliferation 
Increased IL-8 release 
(Peters et al., 2004) 
28 
MPMVEC 
vascular endothelial cells 
No cytotoxicity  
No ROS production 




aortic endothelial cells 
Enhanced endothelial cells proliferation and motility 
Decreased inflammatory and coagulation molecules 
(Peng et al., 2009) 




Table 2.8: Selected publications on TiO2-NPs induced biological responses in the hematopoietic model.  
 
 
Particle size (nm) Model Results Reference 
25 peripheral blood lymphocytes 
Dose and time dependent decrease of cell viability 
Dose dependent increase of ROS levels 




Dose and time dependent decrease of cell viability 
Dose dependent increase of apoptotic cells 
(Wang et al., 2007b) 
25 peripheral blood lymphocytes 
Cell cycle arrest 
Activation of caspases 9, 3, 8, Bid and PARP  
Mitochondria depolarization 
(Kang et al., 2009) 
20 - 30 Human red blood cells No apparent cytotoxicity 
(Rothen-Rutishauser et al., 
2006) 
4 - 6 Human neutrophils 
Dose-dependent induction of irregular shape 
Induction of tyrosine phosphorylation   
Activation of P38 and Erk-1/2 MAPK 
Dose-dependent decrease of apoptosis   
Increase of IL-8 levels 
(Goncalves et al., 2010) 




Though the efforts to identify and catalogue the potential effects of NMs have been 
underway, only a selected tissue types (such as the lung, kidneys and liver) receive the 
majority of the research efforts. It is understandable why these organs and their representative 
cells were selected as the focus of many studies. Their pivotal role in maintaining human 
bodily functions demands a thorough investigation of any possible effect induced by TiO2-
NPs toward them. Nevertheless, the imbalance on the research focus has made the effect of 
TiO2-NPs on other equally important organs relatively unknown. One of such knowledge 
disparities is witnessed regrettably in the vascular system, which covers nearly 240 m
2
 of area 
(equivalent to the size of a tennis court) in human body. The large coverage of this vascular 
beds make them highly accessible for any kind of interaction with the NPs that enter the 
human body (Muro et al., 2004). As such, this blood vessel network warrants more study to 
address its response to TiO2-NPs exposure and interaction.  
 
2.5. Blood vessels and the endothelial cell barrier 
The blood vessel network that spans from head to toe could be considered as the road 
system of human body. The interconnected vascular network allows the blood cells to travel 
the body, carrying with them oxygen and nutrients needed by tissues. In addition, these 
conduits facilitate the removal of carbon dioxide and metabolic wastes from the tissues (Yuan 
and Rigor, 2010c). The transport toward and away from organs is facilitated by 
macrovasculature, which comprises of large capacity conduits like the arteries and the veins. 
The real blood-tissue exchange of solute, however, occurs in the much smaller conduits of 
microvasculature like capillaries, arterioles and venules (Yuan and Rigor, 2010c). In order to 
facilitate this solute exchange, microvasculatures are built extraordinarily thin, with a 
monolayer of endothelial cells lining the vasculature inner wall and occasional pericytes 
found on the outer walls (Aird, 2007; Yuan and Rigor, 2010c). As there is only a monolayer 




of endothelial cells standing between the blood cells and the tissue, this endothelial cell 
monolayer becomes the sole authority to regulate the blood-tissue exchange in the 
microvasculature (Aird, 2007; Yuan and Rigor, 2010c).  
The regulation of solute exchange across the monolayer originates from the monolayer 
structure itself. The closely interconnected endothelial cells form a continuous barrier that 
selectively allows water, protein, and other macromolecules to leave the blood circulation and 
cross over to the tissue. Solute is transported across the barrier through two known routes: the 




Figure 2.7: Paracellular and transcellular route of solute transport across the 
microvascular endothelial cell barrier. Barrier function of endothelial cell monolayer is 
originated from its structure, which is made from closely juxtaposed endothelial cells glued 
together by the intercellular junction proteins. The intercellular gaps between these cells only 
allow passage for certain solutes and fluids (paracellular route). Much larger solutes, 
however, have to take transcellular route, which consist of traversing across the endothelial 
cell interior either via a series of endocytosis, transcytosis and exocytosis processes, or via 
vacuole-vesicular organelles (VVOs). 
 
 




In transcellular route, solutes undergo endocytosis at the luminal side, conveyed across 
the cell intracellularly in vesicles and finally released at the basolateral membrane of the 
endothelial cells by way of exocytosis (Monopoli et al., 2012; Yuan and Rigor, 2010a). A 
typical transcellular transport across endothelial cells is initiated predominantly through 
caveola mediated pathway (Muro et al., 2004), where the solute firstly binds to its specific 
receptor (Yuan and Rigor, 2010a). This binding in turn signals caveola formation wherein the 
cell membrane starts to form cave-like structures, invaginates and contains the solutes, pinchs 
off from the membrane, and finally creates an endocytic vesicle (70 nm) (Muro et al., 2004; 
Yuan and Rigor, 2010a). This vesicle containing solutes is transported across the cell 
presumably through its interaction with the cells microtubules. The vesicle is then 
disassembled when it reaches the cell basolateral portion, releasing the cargo solute at the 
interstitial space of the tissue.  
Alternatively, the solutes could be transported via the vesicle vacuolar organelles 
(VVOs). The VVOs essentially are formed from the same lipid rafts that form the endocytic 
vesicle. However, the rafts are not fully detached to produce a single vesicle, instead they 
become interconnected with each other making a channel structure as big as 80-200 nm that 
spans from the apical to the basolateral portion of the endothelial cell (Muro et al., 2004; 
Yuan and Rigor, 2010a). In addition, transcellular passage could be achieved through 
aquaporin or the water channel. Aquaporins are transmembrane proteins expressed in the 
endothelial cells that permit water movement across the cell membrane. Nevertheless, fluid 
transport via aquaporin is generally insignificant (<10%) as the majority of the fluid transport 
occurs via paracellular route (Yuan and Rigor, 2010a). 
Paracellular (or intercellular) route is only available for transport of fluid and selected 
solutes. The paracellular route selectivity is imposed by the size of the intercellular junction 
between two neighboring endothelial cells in which the solutes need to travel through in order 




to cross the barrier. As such, these intercellular gaps only allow sufficiently small solutes to 
pass through, making the width of these intercellular gaps the determinant of solute transport. 
Endothelial cells in the brain connect intercellular junction extremely tightly, leaving only 1 
nm gap in between them (Yuan and Rigor, 2010a). In the kidneys, the endothelial cell barrier 
is made with fenestrations as big as 60-70 nm (Satchell and Braet, 2009). In the liver, the 
endothelium barrier is discontinued with gaps between endothelial cells that spans as wide as 
100 - 175 nm (Satchell and Braet, 2009). However, these tissues are highly specialized 
tissues and the intercellular gaps that can be found in these tissues are not normally observed 
in the typical microvascular bed. EM micrographs found that typical intercellular gaps are 
formed with the width of 10-25 nm (Oda and Takeichi, 2011; Taveau et al., 2008). 
Paracellular permeability is greatly regulated by the width of the intercellular gaps between 
the endothelial cells. As such, the structural integrity responsible to maintain these 
intercellular gaps in their appropriate width becomes highly pivotal for fully functional 
endothelial cell barrier. 
 
2.6. Maintenance of endothelial cell monolayer integrity 
The structural integrity of a typical endothelial cell barrier is entrusted on the 
intercellular junction proteins that connect two neighboring endothelial cells together and 
essentially dictate the width of the junction. Figure 2.8 depicts the three known types of 
intercellular junctions: adherens junctions; tight junctions; and gap junctions (Dejana, 2004; 
Wallez and Huber, 2008; Yuan and Rigor, 2010a). 






Figure 2.8: Formation of intercellular junctions on endothelial cell barrier. Typical 
intercellular junctions in endothelial cell monolayer are adherens junctions (AJs), tight 
junctions (TJs) and gap junctions. These junctions are maintained by a series of intercellular 
junction proteins that is specific to the particular junction. Claudins, occludin, JAMs and 
ESAM are found in TJs, VE-cadherin is specifically found in AJs, and connexins found in the 
gap junction region. Proteins in TJs and AJs are linked to the cytoskeletal fibers. 
 
 
2.6.1. Adherens Junctions  (AJs) 
Adherens junctions or AJs are ubiquitous in the microvascular barrier. In addition, they 
are the major junction type in the microvasculature. As such, AJs are the determining factor 
for endothelial barrier capability to sieve macromolecules in many organs and tissues (Dejana 
et al., 2008; Yuan and Rigor, 2010a). At the AJs, structural stability is maintained primarily 
through homophilic interaction of the transmembrane protein vascular endothelial cadherin 
(VE-cadherin). Typically, the interaction occurs between the extracellular domains of a VE-
cadherin molecule of adjacent cells. The homophilic bonds between VE-cadherin are formed 
throughout the length of the two cells, making a zipper-like structure (Figure 2.9A) that glues 




these adjacent cells together (Dejana, 2004; Dejana et al., 2008). VE-cadherin homophilic 
interaction depends heavily on the presence of extracellular Ca
2+
 ions. The ions facilitate the 
interaction by binding to the negative domains of VE-cadherin, thus giving the VE-cadherin 
the required protein conformation to allow the interaction (Dejana et al., 2008; Yuan and 
Rigor, 2010a) .  
 
Figure 2.9: Adherens junctions in endothelial cell barrier. The AJs of endothelial cell 
barrier are maintained primarily through VE-cadherin homophilic interaction. (A) The 
homophilic interaction forms a zipper like structure that allows the AJs to have the precise 
size necessary to exclude macromolecule diffusion. (B) Stability of the AJs is also maintained 
with the help of VE-cadherin intracellular connection to the actin cytoskeleton through the 
intermediary proteins α- and β-catenin. In addition, VE-cadherin interaction with p120-
catenin desists the internalization and degradation of the VE-cadherin, allowing the zipper-
like structure to be maintained.  
 
The stability of endothelial cell barrier structure is bolstered further by the connection 
of intracellular VE-cadherin domain to actin cytoskeleton. The connection between VE-
cadherin and actin is facilitated by an intermediary protein, β-catenin, which binds to both the 
intracellular domain of the VE-cadherin and α-catenin (Figure 2.9 B). The α-catenin in turn 
binds itself to actin cytoskeleton, making a cadherin-catenin-actin complex (Figure 2.9 B) 
that stabilizes the AJ structure and subsequently the endothelial cell barrier structure (Dejana 
et al., 1999; Dejana et al., 2008). In addition to direct stabilization through the cadherin-




catenin-actin complex, AJ stability is also indirectly influenced by binding of VE-cadherin to 
p120 (Figure 2.9 B). This binding maintains VE-cadherin localization at the junction at all 
time. The loss of binding of p120 to VE-cadherin has been shown to result in the 
internalization and degradation of the VE-cadherin from the AJs, resulting in the increase of 
endothelial cell barrier permeability. 
 
2.6.2. Tight Junctions (TJs) 
In many ways the TJs are built to model the AJs. The TJs are maintained by a series of 
tight junction proteins, namely occludin and claudin-5. These TJs proteins are transmembrane 
proteins that possess two extracellular loop domains in each molecule. Similar to AJs, the TJs 
stability is derived from the homophilic interaction made by TJs proteins on adjacent cells 
(Dejana, 2004; Yuan and Rigor, 2010a). 
It is worth noting that, unlike ubiquitous AJs in the endothelial cell barrier, the TJs are 
mainly conserved in certain tissue types, like brain and retina (Hawkins and Davis, 2005; 
Yuan and Rigor, 2010a).  The TJs proffer additional barrier function, making these tissues 
highly inaccessible for many solutes including small ions like Na
+
 (Dejana, 2004; Hawkins 
and Davis, 2005; Yuan and Rigor, 2010a).  
 
2.6.3. Gap junctions 
Gap junctions are formed due to the presence of six units of connexins in the region. 
Similar to other junctions, each endothelial cell proffers a bundle of connnexins that interacts 
in a space between the two cells (Dejana et al., 2008). The interaction results in a connective 
channel between the cytoplasmic compartments of the two cells. This allows these cells to 
share signal molecules and communicate with each other. Therefore, the gap junctions do not 
participate actively in the maintenance of endothelial cell barrier integrity (Dejana et al., 




2008). Nevertheless, these junctions could promote instability in the endothelial cell barrier 
structure via cell-cell signaling. 
 
2.7. Endothelial cell barrier leakiness  
Due to its important role as a gate keeper of the blood circulation, endothelial cell 
monolayer permeability is under tight and precise regulation. There are only few compounds 
that are able to regulate its permeability. Histamine, Vascular Endothelial Growth Factor 
(VEGF), and ROS are among those selected few that can increase paracellular permeability 
of solutes across the endothelial cell barrier and induce leakiness of this endothelial cell 
barrier.  
VEGF is an angiogenic compound responsible to promote blood vessel growth. 
Nevertheless, VEGF also has been reported to induce leakiness on the endothelial barrier 
mostly in cases like tumor development and diabetic retinopathy (Weis and Cheresh, 2005; 
Yuan and Rigor, 2010b). VEGF-induced vascular leakiness is initiated by the compound 





which in turn activate the intracellular kinases like Src kinase and MAP 
kinase to phosphorylate the protein effectors of barrier leakiness (Bates et al., 2002). It has 
been reported that VEGF treatment resulted in the tyrosine phosphorylation of VE-cadherin, 
β-catenin, p120 and platelet endothelial cell adhesion molecule-1 (PECAM-1) (Esser et al., 
1998; Lum and Roebuck, 2001). The phosphorylation of these proteins in turn results in the 
degradation of the proteins, destabilization of the AJ and increase of barrier leakiness (Dejana 
et al., 2008; Yuan and Rigor, 2010b). 
In a similar manner, histamine activates its receptor upon binding to send out signals to 
the endoplasmic reticulum for the release of Ca
2+ 
ions. The imbalance of Ca
2+ 
ions then 
activates the intracellular kinases that phosphorylate the multiple AJ proteins. This in turn 




destabilizes the junctions and reduces the overall selectivity of the barrier (Andriopoulou et 
al., 1999; Yuan and Rigor, 2010b). 
Another possible leakiness-inducing compound is ROS. ROS, which normally is 
generated during inflammation or in the presence of ROS-producing NPs, could also 
destabilize the endothelial barrier integrity by altering intracellular Ca
2+ 
regulation. ROS has 
been reported to attack the Ca
2+
-ATPase, the enzyme responsible to reduce the amount of 
intracellular Ca
2+
 in order to maintain homeostatic status. This enzyme dysfunction results in 
the increase of intracellular Ca
2+
, inducing phosphorylation of leakiness inducing 
phosphorylation protein effector of leakiness and as a result, the endothelium barrier structure 
is compromised (Lum and Roebuck, 2001).  
 
2.8. TiO2-NPs and endothelial cells interaction: the knowledge gap 
In light of the important role of the endothelial cell barrier, there is a need to identify 
the possible damaging outcome when it encounters and interacts with NPs.  At the start of 
this study, only a handful of publications have documented the possible impairment of the 
endothelial cell barrier function due to interaction with  NMs. Apopa et al. (2009) reported 
that NMs possess the capability to induce endothelial cell permeability through the 
modulation of ROS. The authors suggested that ROS regulation induced by iron oxide NMs 
could induce remodeling in the cytoskeleton (Apopa et al., 2009). Though the study gives an 
insight into how ROS inducing NMs could induce leakiness on endothelial cell barrier, their 
study might not applicable to all types of NMs due to different ROS-inducing capability of 
each NMs. It is then necessary to investigate whether the TiO2-NPs could induce enough 
intracellular ROS to instigate the endothelial cell leakiness through the mechanism proposed 
by Apopa et al. (2009). 




A more recent study by Brun et al. (2012), who utilized P25 Aeroxide TiO2-NPs, 
suggested that these NPs could induce leakiness in rat brain endothelial cells. The NPs were 
reported to increase the expression of the chemokines that in turn induced the down 
regulation of the tight junction proteins expression thus leading to brain endothelial cell 
leakiness. Though important in understanding the potential effect on brain endothelial cells, 
this type of endothelial cells is highly specialized. As previously mentioned in section 2.6, 
brain endothelial cells are constructed differently from other type of endothelial cells. The 
added tight junction proteins in the brain endothelial cells are not observed in other type of 
endothelial cells. Hence, there is a high possibility that the phenomenon reported (Brun et al., 
2012) would not occur in the more commonly found endothelial cells. 
Moreover, all these studies suggested different cause of endothelial cell barrier 
leakiness. This suggests the complexity of the interaction between NMs and endothelial cells. 
Hence, more studies are required in order to fully understand the potential effect of NMs 
interaction with endothelial cells, especially with respect to the impairment of the endothelial 
cell barrier. 
 
2.9. Problem statement and scope of study 
Humans are constantly exposed to NMs, leading to the need to study the biological 
response stimulated by these NMs. Current knowledge on the subject of biological response 
elicited by NMs is limited to the major organs. Blood vessel network is one of the largest 









In this study, the TiO2-NPs and endothelial cells were used as model to fulfill the 
following aims: 
1. Investigate the possible interaction between TiO2-NPs and endothelial cells, especially 
with respect to the impairment of the endothelial cell barrier 
2. Investigate the mechanism which triggers the observed phenomenon 
3. Provide in vivo validation for the observed in vitro phenomenon 
The result presented in this study could give better understanding on how the NMs could 
impair the endothelial cell barrier. This understanding will bring fundamental knowledge to 
the field, enabling material scientists to better design NMs that preserve vascular integrity 
and avoid deposition into major organs.  
Undoubtedly, there are various NMs being produced and utilized that warrant in-depth 
study on their interaction with endothelial cell monolayer. Nevertheless, due to time 
constraints, this study will focus mainly on the prevalently used NMs, TiO2-NPs. Though it is 
tempting to study whether NMs also could elicit an effect on other types of barriers which 
share phenotypic function, such as blood-brain barrier, glomeruli barrier, colorectal and 
rectum epithelial barrier, this study will only cover the impact of NMs on the microvascular 







Materials and Methods 
 






Primary human microvascular endothelial cells (HMVECs) of neonatal origin were 
purchased from Life Technologies, USA. Murine melanoma cells (B16F10; ATCC CRL-
6475) were a kind gift from Dr Tan Nguan Soon. 
 
3.1.2. Animals 
BALB/c white mice and wild type C57BL/6J mice at the age of three weeks old were 
used in the in vivo study.  
 
3.1.3. Chemicals 
TiO2-NPs were obtained from Evonik Degussa, USA. EndoGRO-MV-VEGF cell 
culture medium, Immobilon
TM
 Western Chemiluminescent HRP substrate, and vascular 
endothelial growth factor (VEGF) were purchased from Merck Millipore, USA. 2',7'-
dichlorofluorescin diacetate (DCFH-DA), 4-(2-hydroxyetyl)-1-piperazineethanesulfonic acid 
(HEPES), aminopropyltriethoxysilane (APTES), bovine serum albumin (BSA), bromophenol 
blue, calcium chloride (CaCl2), chloroquine, ethylenediaminetetraacetic acid (EDTA), 
ethylene glycol tetra acetic acid (EGTA), eosin stain, Evans blue dye, fluorescein 
isothiocyanate (FITC), FITC-dextran (MWav= 40,000), glutaraldehyde, glycine, histamine, 
magnesium chloride (MgCl2), MG132 proteosomal inhibitor, β-mercaptoethanol, methyl-β-
cyclodextrin (MβCD), monodansylcadaverine (MDC), monopotassium phosphate (KH2PO4), 
NP-40, paraformaldehyde, phosphatase inhibitor cocktail, potassium chloride (KCl), PP1 
inhibitor, protease inhibitor cocktail, sodium chloride (NaCl), sodium dodecyl sulfate (SDS), 
sodium diphosphate (Na2HPO4), TiO2 microparticles, Tris, Triton X-100, Tween 20 and Y-
27632 ROCK inhibitor were purchased from Sigma Aldrich, USA. Ethanol, hydrochloric 




acid (HCl) and methanol were obtained from Fisher Scientific, USA. Fetal bovine serum 
(FBS), Hoechst 33342 stain, ProLong® Gold antifade reagent with DAPI and Tali® Viability 
kit were acquired from Life Technologies, USA. Gel for SDS – polyacrylamide gel 
electrophoresis (SDS – PAGE) was obtained from Biorad Laboratories Inc., USA. Mem-PER 
membrane protein extraction kit and RevertAid H-Minus First Strand cDNA Synthesis kit 
were purchased from Thermo Scientific, USA. O.C.T. Tissue Freezing Compound was 
acquired from Leica Microsystems, USA. Duolink proximity ligation assay was obtained 
from Olink Bioscience, Sweden.  RNeasy fibrous tissue mini kit and SYBR Fast Universal 
qPCR kit were purchased from Qiagen, USA and KAPA Biosystems, USA, respectively. 
 
3.1.4. Antibodies 
Rabbit anti-VE-cadherin, rabbit anti-caspase 3, mouse anti-caspase 8, rabbit anti-
caspase 9, rabbit anti-PARP, rabbit anti-p120 and mouse anti-SOD1 were obtained from Cell 
Signaling, USA. Mouse anti-α-tubulin was purchased from Sigma Aldrich. Alexa 488-
Phalloidin and Alexa 488-chicken anti-rabbit was bought from Life Technologies, USA. 
Rabbit anti-β-catenin, mouse anti-β-actin, horseradish peroxidase (HRP) conjugated goat 
anti-mouse, HRP conjugated goat anti-rabbit and Protein A Agarose were acquired from 
Santa Cruz Biotechnologies, USA. Mouse IgG, mouse anti-VE-cadherin (BV6) and rabbit 
anti-phospho-VE-cadherin (Y658) were obtained from Merck Millipore, USA. Rabbit anti- 
phospho-VE-cadherin (Y731) and rabbit anti-claudin 5 were bought from Life Technologies, 










The buffers used in this study were prepared with the following composition: 
 Phosphate buffered saline (PBS)  
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4. pH 7.4 
 Laemmli’s sample buffer  
60 mM Tris-HCl (pH 6.8), 2% SDS, 10% glycerol, 5% β-mercaptoethanol, 0.01% 
bromophenol blue.  
 Immunoprecipitation (IP) lysis buffer 
10 mM Tris-HCl (pH 7.4), 1 mM EDTA, 150 mM NaCl, 1 mM EGTA (pH 8.0), 1% 
Triton X-100, 0.5% NP-40.  
 Radio Immunoprecipitation Assay (RIPA) lysis buffer 
25 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1% NP-40, 0.1% SDS. 
 Immunoblotting transfer buffer  
25 mM Tris, 192 mM glycine, 10% methanol, 0.05% SDS. 
 Tris buffered saline  with Tween 20 (TBST) 
20 mM Tris-HCl (pH 7.4), 137 mM NaCl, 0.05% Tween 20.  
 Tris-EDTA (TE) 
10 mM Tris-HCl (pH 8), 1 mM EDTA (pH 8). 
 Potassium depletion buffer 











3.2.1. Cell culture 
HMVECs were grown in EndoGRO-MV-VEGF in a standard cell culture condition of 
37
o
C, 5% CO2. The cells were fed every two days by changing the culture media. In addition, 
the cells were sub-cultured when they reached 90% confluence.  
The cells were seeded at seeding density of 40,000 cells/cm
2 
and were let to form 
endothelial cell monolayer prior to any treatment.
  
 
3.2.2. TiO2-NPs characterization 
TiO2-NPs morphology was observed with the help of transmission electron 
microscopy (TEM; JEOL JEM 2010, Japan). Briefly, TiO2-NPs (10 µg/mL) were dispersed 
in ethanol with sonication and then a drop of the TiO2-NPs suspension was placed onto 
carbon coated grids. In addition to morphology observation, TEM micrographs were used to 
obtain the primary particle size of TiO2-NPs. Primary particle size data were derived by 
scoring 100 randomly chosen NPs using ImageJ software (www.rsbweb.nih.gov/ij/). In order 
to have a better understanding of the actual TiO2-NPs behavior in aqueous solution, TiO2-
NPs were dispersed in the different dispersants and measured for hydrodynamic size as well 
as the ζ-potential using Dynamic Light Scattering (DLS; Malvern, UK). Each sample was 
measured in triplicate, and the mean values were reported. 
 
3.2.3. Preparation of TiO2-NPs suspensions 
TiO2-NPs suspensions were prepared by adding the NMs into the various solvents 
used in this study, namely ultrapure water, EndoGRO-MV-VEGF media, PBS and BSA 
supplemented PBS. The formation of TiO2-NPs dispersion was assisted with probe sonication 




(Micronson XL2000, QSonica, USA) for 1 minute. The TiO2-NPs concentrations used in this 
study are listed in the following table: 









5 0.4 0.08 
10 0.8 0.16 
50 4 0.8 
100 8 1.6 
250 20 4 
500 40 8 
1250 100 20 
a
mL – growth media volume; bcm2 – area of cell growth 
 
3.2.4. Immunofluorescence staining 
Endothelial cell barrier integrity was visualized by immunofluorescence staining 
technique. HMVECs were grown on 8-well chamber slide and following the confirmation of 
HMVECs monolayer formation, the cells were treated by replacing the growth medium with 
medium containing suspended TiO2-NPs at various time points. Thereafter, the media was 
removed and the cells were gently washed with PBS.  The cells then were fixed with 4% 
paraformaldehyde for 15 minutes, permeabilized using 0.2% Triton X-100 for 15 minutes and 
blocked for 1 hour with 2% BSA and 0.1% Triton X-100 in PBS. Fixed cells were incubated 
overnight at 4
o
C with anti-VE-cadherin antibody (1:200) in 0.2% BSA. Thereafter, the cells 
were washed thrice with PBS, and incubated for 1 hour at room temperature with Alexa 488-
chicken anti-rabbit antibody (1:400). Finally, the labeled slides were mounted using 
ProLong® Gold antifade reagent with DAPI. Finally, the images were obtained using Nikon 
A1 confocal microscope (Nikon, Japan). 
 




3.2.5. Permeability Transwell® Assay 
 The degree of endothelial cell leakiness was measured in Transwell
®
 insert (with 
polycarbonate ﬁlter, 0.4 μm pore; Corning Costar, Cambridge, MA) as described by Taddei 
et al. (2008). Briefly, HMVECs were cultured with density of 20,000 cells/well for two days 
to achieve a confluent monolayer. Thereafter, NPs or microparticles suspensions were added 
to cells in addition to FITC-dextran (1 mg/mL). Following 30 minutes treatment, 100 μL of 
samples were taken from the lower compartment and the fluorescence signal was quantified 
with a microplate reader (Tecan Infinite 200) at excitation/emission wavelength of 490/520 
nm. As positive control, the HMVECs monolayer was treated with 2.5 mM of EDTA. Data 
represent the mean of three independent experiments. 
 
3.2.6. Reactive oxygen species (ROS) level measurement 
HMVECs were grown on 96-well plates at 20,000 cells/well overnight. Media was 
replaced with media containing different concentration of TiO2-NPs and incubated for 0.5, 1, 
2, 4, 8, 12 and 24 hours. At the end of the exposure time, the cells were exposed to a cocktail 
of 10 µM of DCFH-DA and 1 μg/mL of Hoechst 33342 for 30 minutes. Afterwards, the cells 
were washed twice with PBS. The intracellular ROS level was obtained by detecting the 
oxidized form of DCFH-DA, 2',7'-Dichlorofluorescin (DCF). In addition, the intracellular 
ROS level was normalized against the total amount of cells, as detected with Hoechst 33342. 
The fluorescence readout obtained for excitation/emission wavelengths of 488/525 nm and 
350/461 nm were used to determine the intensities of DCF and Hoechst 33342 dye, 
respectively. As positive control, HMVECs were also incubated with hydrogen peroxide 
(H2O2; Sigma Aldrich, USA) with concentration of 200 µM for 2 hours. Data represent the 
mean of three independent experiments. 
 




3.2.7. Cell viability measurement 
HMVECs were grown on 24-well plates at 40,000 cells/cm
2 
overnight. Media was 
replaced with media containing different concentration of TiO2-NPs and incubated for 0.5, 1, 
3, 6, 9, 12, 24, and 48 hours. At the end of the exposure time, all detached and adherent cells 
were collected. The cells then were washed with PBS and then stained with Tali® Viability 
kit for 5 minutes in the dark. Following that, the cells were analyzed with Tali® Image Based 
Cytometer. As positive control, cells were treated with 0.2% Triton X-100 for 1 minute prior 
to the staining process. Data represent the mean of three independent experiments.  
 
3.2.8. Protein extraction and immunoblotting 
All lysis buffers used in the study were supplemented with cocktails of 1% protease 
inhibitors and 1% phosphatase inhibitors. Protein extracts were resolved using gradient 
precast SDS – PAGE gel and then electro-transferred onto a nitrocellulose membrane in 
immunoblotting transfer buffer. The nitrocellulose membrane was blocked with 2% BSA in 
TBST and then followed by antibody probing, as per manufacturers’ instructions. The 
detection was assisted by secondary antibodies; HRP-conjugated goat anti-mouse and HRP-
conjugated goat anti-rabbit which were used at dilution 1:10000. Specific protein bands were 
detected using Immobilon
TM
 Western Chemiluminescent HRP substrate with 
Chemiluminescence Imaging System (Syngene, UK). 
For apoptotic signaling pathway, confluent monolayer HMVECs were treated with 
various concentrations of TiO2-NPs (0, 250, 500, and 1250 µM). At different time points (1, 
3, and 24 hours), the cells were lysed with Laemmli’s sample buffer. The lysate was 
separated with SDS-PAGE and then electro-transferred onto nitrocellulose membrane. 
Apoptosis markers were detected by employing the following primary antibodies: anti-




caspase 3 (1:1000), anti-caspase 8 (1:1000), anti-caspase 9 (1:1000), anti-PARP (1:1000) and 
anti-α-tubulin (1:5000). 
 
3.2.9. Preparation of FITC-TiO2-NPs 
TiO2-NPs (100 mg) were added in anhydrous ethanol (100 mL) and dispersed with 
the help of sonication for 5 minutes. Following complete dispersion, 5 mL of APTES was 
added drop wise to the suspension and stirred at 80°C for 3 hours. Then, 25 mg of FITC was 
added to the mixture and was stirred for another 16 hours at 80°C. At the end of the reaction, 
the FITC-TiO2-NPs were collected, thoroughly washed with ethanol and ultrapure water to 
remove free FITC. Finally, the FITC-TiO2-NPs were freeze-dried and stored at room 
temperature until further use. 
 
3.2.10. Confocal imaging of internalized TiO2-NPs 
The internalization of TiO2-NPs was detected by treating the cells with 1250 µM of 
FITC-TiO2-NPs for 30, 60 and 180 minutes. At the end of the exposure time, the cells were 
washed to remove the non-internalized FITC-TiO2-NPs. The NPs uptake was detected with 
confocal imaging (Nikon TE 2000-E, Japan) without cell fixation. 
For studying endothelial cell barrier integrity following the endocytosis block, the 
monolayer HMVECs were pretreated with the endocytosis blockers (10 µM MDC or 5 mM 
MβCD) for 1 hour followed with TiO2-NPs (50 and 250 µM) exposure for 30 minutes. 
Afterwards, the cells were washed and processed for immunofluorescence visualization 








3.2.11. Quantification of internalized of TiO2-NPs 
In order to further confirm the effect of TiO2-NPs internalization on endothelial cell 
barrier integrity, endocytosis inhibitors were employed to block the internalization pathway. 
The cells were pretreated with endocytosis inhibitors (10 µM MDC or 5 mM MβCD) for 1 
hour prior to FITC-TiO2-NPs exposure. In order to measure the TiO2-NPs uptake after the 
blocking the endocytosis pathways, the cells were treated with FITC-TiO2-NPs (50 and 250 
µM) for 30, 60, and 120 minutes. Subsequently, the cells were washed to remove the non-
internalized FITC-TiO2-NPs. For measurement of total internalized TiO2-NPs the cells then 
were lysed with 0.1% Triton X-100 in TE buffer, while lysis buffer from Mem-PER 
Membrane protein extraction kit were used to study the location of internalized TiO2-NPs. 
The lysates were collected and Hoechst 33342 stain (1 µg/mL) was added. The mixtures then 
were moved into a black 96-well plate, where the fluorescence intensity was measured at an 
excitation/emission wavelength of 488 nm/520 nm. The reading were normalized against the 
amount of DNA which was obtained from the Hoechst 33342 signals (Excitation/Emission = 
350 nm/461 nm). 
 
3.2.12. TiO2-NPs pulldown  
For TiO2-NPs pulldown experiment, confluent monolayer of HMVECs was treated 
with TiO2-NPs (10, 100, and 500 μM) for 1 hour. Following the treatment, the protein was 
extracted with RIPA buffer. TiO2-NPs along with their associated proteins were pelleted out 
by centrifugation at 1000×g, 5 minutes, 4°C. Once obtained, TiO2-NPs pellet were washed 
thrice with RIPA buffer and the associated protein was eluted from the pellet by boiling for 5 
minutes in Laemmli’s sample buffer. Post-lysis pulldown experiments were carried out by 
lysing the cells with RIPA buffer and adding either TiO2-NPs (final concentration of 500 
µM) or Protein A Agarose (Mock). The mixtures then were gently shaken for 1 hour at 4°C. 




Afterwards, the TiO2-NPs and the Agarose beads were pelleted out and subjected to the same 
washing and eluting treatment as indicated before. The proteins extracted then were separated 
and electro-transferred following the immunoblotting procedure mentioned before in section 
3.2.7. Membrane then was probed with antibodies against VE-cadherin (1:1000), α-tubulin 
(1:5000), Claudin-5 (1:1000), and SOD1 (1:500). Schematic of TiO2-NPs pulldown 
experiment are provided in Scheme 3.1 
 
Scheme 3.1: Schematic presentation of TiO2-NPs assisted protein precipitation. TiO2-
NPs and any interacting proteins were isolated together through centrifugation. Following 
washing to remove unbound proteins, the bound proteins were eluted out with Laemlli’s 
sample buffer and the detection was conducted with immunoblotting technique.  As control, 
post-lysis addition of TiO2-NPs (P) and agarose beads (A) was also introduced. 
 
 
3.2.13. Preparation of  mouse IgG-conjugated TiO2-NPs 
Prior to conjugating mouse IgG to TiO2-NPs, the NPs were treated with APTES to 
produced silanized TiO2-NPs following the procedure mentioned in section 3.2.8. 
Afterwards, 10 mg of silanized TiO2-NPs was activated with 1.5mL of 8% Glutaraldehyde 
(Sigma Aldrich, USA) for 6 hours in room temperature. Thereafter, the activated TiO2-NPs 
were collected, washed thrice with PBS and resuspended in 4 mL of PBS.  The activated 
TiO2-NPs suspension (160 μL; equivalent to 400 μg of activated TiO2-NPs) were added to 1 
mL of PBS solution mouse IgG (20 μg). The mixture then was gently agitated for 16 hours in 
4°C. Following the conjugation process, the mouse IgG-conjugated TiO2-NPs were collected 




and washed thrice with PBS. The mouse IgG-conjugated TiO2-NPs were resuspended in PBS 
solution and stored in 4°C until further use. Conjugation scheme is found in Scheme 3.2. 
 
 
Scheme 3.2: Schematic illustrating mouse IgG-conjugation to TiO2-NPs. Pristine TiO2-
NPs were reacted with APTES to form silanized TiO2-NPs. Following the formation of 




3.2.14. Proximity Ligation Assay (PLA)  
PLA semi-quantification was done by introducing mouse IgG-conjugated TiO2-NPs 
to a HMVECs monolayer culture. Following treatment, the cells were washed thrice with 
PBS and fixed with 4% paraformaldehyde. Cell cytoplasm was visualized by staining actin 
with Alexa-488-Phalloidin (1:40). The detection of PLA signal was done with Duolink In 
Situ Proximity Ligation Assay, as per supplier’s instructions. Schematic PLA assay is found 
in Scheme 3.3. The PLA signals were quantified with Duolink ImageTool software (Olink 
Bioscience, Sweden) and normalized against the cell number (n=25). 






Scheme 3.3: Schematic illustrating PLA assay with mouse IgG-TiO2-NPs. Interaction 
between mouse IgG-TiO2-NPs and VE-cadherin was probed by adding addition of primary 
antibody that specifically recognizes VE-cadherin and rabbit anti-VE-cadherin (1). 
Afterward, Duolink In Situ PLA probes, anti-mouse PLUS and anti-rabbit MINUS, were 
introduced to the sample and recognized their respective primary antibody (2). Both 
secondary probes were conjugated with complementary oligonucleotide. Due to the direct 
interaction of TiO2-NPs and VE-cadherin (distance <40 nm), these complement 
oligonucleotide strands were in the vicinity of each other, allowing them to hybridize. 
Following that, the complement oligonucleotide strands were ligated and amplified with 
Rolling Circle Amplification (RCA) (3). The amplified RCA strands then were detected with 
the addition of complement red-fluorescent labelled oligonucleotide, giving positive PLA 
signal (4).  
 




3.2.15. Immunoblotting detection of VE-cadherin phosphorylation  
HMVECs were grown to confluence and serum starved for 6 hours prior to 
pretreatment with 10 µM of PP1 inhibitor for 1 hour. Following pretreatment, the cells were 
subjected to different treatments: 50 and 100 ng/mL of VEGF, 100 µM of Histamine, 10 mM 
of EDTA, and 250 µM of TiO2-NPs for the time point indicated. Afterwards, the proteins 
were separated and electro-transferred following the immunoblotting procedure in section 
3.2.7. VE-cadherin phosphorylation was detected with specific antibody anti-phospho-VE-
cadherin Y658 (1:1000) and anti-phospho-VE-cadherin Y731 (1:1000). Total VE-cadherin 
was detected with anti-VE-cadherin (1:1000). 
 
3.2.16. Immunoprecipitation 
For Immunoprecipitation (IP) experiment, confluent monolayer was treated with 250 
µM of TiO2-NPs for 15, 30, and 60 minutes. The cells were lysed with IP lysis buffer. 
Afterwards, the lysate was separated into three parts, in which each part was incubated at 
4°C, overnight with antibody against one of the following targets: VE-cadherin, β-catenin, 
and p120. Following that, the antibodies were precipitated using Protein A Agarose. Proteins 
were released by boiling for 5 minutes in Laemmli’s sample buffer. Afterwards, the protein 
was separated and electro-transferred following the immunoblotting procedure mentioned 
before in section 3.2.7. The membranes were probed with antibody against VE-cadherin 
(1:1000), β-catenin (1:1000) and p120 (1:1000).  
 
3.2.17. Immunoblotting determination of VE-cadherin internalization and degradation  
For internalization study, confluent monolayer HMVECs were either pretreated with 
endocytosis inhibitor MDC (10 µM) or potassium depletion buffer for 1 hour. For 
degradation study, confluent HMVECs were either pretreated with 100 µM of chloroquine or 




10 µM of MG132 for 6 hours. Afterwards, the cells were subjected to treatment with VEGF 
(100 ng/mL), Histamine (100 µM) or TiO2-NPs (250 µM) for 30 minutes. In order to 
distinguish the VE-cadherin in cell surface and the intracellular pool of VE-cadherin, the 
treated HMVEC were rinsed twice with PBS and incubated in Trypsin/EDTA solution in 
37°C for 3 minutes to proteotically remove extracellular VE-cadherin as described previously 
(Xiao et al., 2005). As control, parallel cultures were harvested in standard Laemmli’s sample 
buffer without trypsinization. The cell lysate were separated with SDS-PAGE and 
immobilized on to nitrocellulose membrane following protocol mentioned in section 3.2.7. 
Immunoblots were probed with anti-VE-cadherin BV6 antibody (1:2000) that specifically 
recognizes the extracellular domain of VE-cadherin.  
 
3.2.18. Immunofluorescence detection of VE-cadherin internalization 
VE-cadherin internalization assay was performed in accordance to previous report  
(Xiao et al., 2003). Briefly, confluent HMVECs were serum starved for 6 hours. Three hours 
into the serum starvation, chloroquine (150 μM) was added to prevent lysosomal degradation 
of the internalized VE-cadherin. Cells were subsequently incubated with anti-VE-cadherin 
BV6 (1:100) antibody in medium containing 3% FBS at 4°C for 1 hour. Cells were then 
rinsed with ice cold, serum free medium to remove excess unbound antibodies and then 
treated with the various stimuli for 30 minutes at 37°C. Cells were washed with PBS or in 
mild acidic buffer (pH 2.7) containing 3% BSA and 25 mM glycine in order to remove 
surface bound VE-cadherin. Thereafter, the cells were washed and processed for 








3.2.19. ROCK inhibition assay 




 either in 8-well 
chamber slide or 24 well Transwell® and grown until confluent. Monolayer of confluent 
HMVECs were then rinsed 3 times with PBS and serum starved for 6 hours at 37°C, 5% CO2. 
Afterwards, cells were pre-treated with Y-27632 ROCK inhibitor (5 and 10 μM) for 1 hour 
prior to the addition of TiO2-NPs. 30 minutes post TiO2-NPs treatment, cells were then either 
processed for immunostaining or subjected to Transwell® assay as mentioned in section 
3.2.4 and section 3.2.5, respectively. 
 
3.2.20. Animal handling  
Experimental protocols were approved by Nanyang Technological University 
Institutional Animal Care and Use Committee (A-0174AZ). Animal handling (sample 
injection and organ harvesting) was done by Dr Kelvin Han Chung Chong. 
 
3.2.21. In vivo subcutaneous vascular leakiness assay 
BALB/c white mice were anesthetized and subcutaneously injected with either TiO2-
NPs or vehicle buffer (3% BSA in PBS). Injection sites were randomly chosen to avoid bias. 
In order to determine vascular permeability, Evans blue dye was injected into the tail vein. 
The mice were sacrificed after 15 minutes and thereafter, the skin was excised and the 
extravasated dye was extracted. Finally, the amount of extravasated EBD was quantified by 
measuring absorbance at 624nm with microplate reader (Tecan Inc., USA). The absorbance 








3.2.22. In vivo murine melanoma-lung metastasis model 
For acute study, wild type C57BL/6J mice were intravenously injected with 1 million 
B16F10 melanoma cells. The mice were treated either with TiO2-NPs suspended in 1% BSA 
in PBS (50 and 150 mg/kg BW) or vehicle control of 1% BSA in PBS. TiO2-NPs samples 
were freshly prepared and were intravenously injected into each mouse every 2 days from 
day 0. At day 7, after receiving total of 3 treatment boluses, the mice were sacrificed and 
lungs were collected for further analysis.   
For subchronic study, wild type C57BL/6J mice were divided into three groups of 
treatment. One group received 1% BSA in PBS (vehicle control), another received 5 mg/kg 
TiO2-NPs, and the last group received 10 mg/kg of TiO2 microparticles. All TiO2 suspensions 
were freshly prepared prior to the injections which were given every other day. At week 
three, after the mice received a total of 7 treatments, 500,000 murine melanoma cells were 
injected via tail vein. The TiO2 treatment was carried on for another week, totaling the 
treatment received by the mice to be 10 boluses. At week 4, the mice were sacrificed and 
their lungs were collected for further analysis. 
 
3.2.23. RNA extraction and real time qPCR 
Total cellular RNA was extracted from approximately 20 mg of lung samples using 
the RNeasy fibrous tissue mini kit according to the recommended protocol. The extracted 
RNA was reverse transcribed to cDNA using RevertAid H-Minus First Strand cDNA 
Synthesis kit, and the metastasis burden was quantified with qPCR of melanin A.  The qPCR 
reactions were performed on ABI 7300 Prism system (Applied Biosystem, USA) using the 
SYBR Fast Universal qPCR kit. Housekeeping gene encodes for ribosomal protein L27 was 
used to normalize the melanin A reading. Primers used in the study were listed in Table 3.2. 
 




Table 3.2: Real time qPCR primer sequences 









5’- CTG GTG GCT GGA 
ATT GAC CGC TA -3’ 
5’ CAA GGG GAT ATC 





5’-TGG ATA CAG AAC 
CTT GAT GGA CA -3’ 
5’ GGG CTG ATG GGA 
TTT CTC  TTG -3’ 
 
 
3.2.24. Histology scoring 
Lung samples were fixed with 4% paraformaldehyde, embedded with O.C.T. Tissue 
Freezing Compound and then frozen with liquid N2. The fixed lung samples were then 
cryosectioned at a thickness of 10 µm (Leica Microsystems CM1850, USA). The sections 
were stained with eosin and were blind-scored by 10 independent assessors. The degree of 
melanoma infiltration was scored with 5 and 0 as the highest and lowest scores, respectively. 
The tumor infiltration degree was also assessed with image based analysis. Random bright 
field images of cryosectioned lung tissues were acquired from biological samples for each 
experimental group. Specimens were imaged with a 10× objective lens, with Olympus 
CKX41 (Japan). Percentage coverage of melanoma in lung tissue was quantified using 
ImageJ software (Scheme 3.4)  






Scheme 3.4: Image based analysis of lung section for tumor infiltration degree 
determination. The analysis was conducted by first converting the lung section image to 
gray-scale image (8-bit) to enable the differentiation of color intensity. As tumor region gave 
way higher intensity, ImageJ was then set to recognize those higher intensity regions, 
allowing the determination of area occupied by the melanoma (AFmelanoma). Following that, 
the image intensity was adjusted to allow the whole lung tissue area (AFlung tissue). Percentage 
area that was occupied by tumor was derived by normalizing the melanoma occupied area 




3.2.25. Statistical analysis  
Result reported for all experiments in this study is expressed as mean ± standard 
deviation of at least three independent experiments. Statistical significance was ascertained 

















As previously discussed in Chapter 2, nanotechnological advances have allowed 
considerable amount of NPs to be produced and utilized each year. Along with the 
exponential increase of NPs production and utilization, humans are increasingly exposed to 
them. This increase of exposure could result with biopersistence of NPs in various major 
organs, giving them further chance to interact with cells. Given that blood vessels and the 
endothelial cell lining are pervasive in the human body, there is a need to understand whether 
NPs could exert any effect on the endothelial cells and impair the important function of blood 
vessels.  
In this chapter, the effect of TiO2-NPs on HMVECs is discussed. In particular, the 
effect of TiO2-NPs on the main function of endothelial cells in maintaining barrier integrity 
necessary for control of nutrient transport in and out of the blood vessel. 
 
4.1. Results 
4.1.1. TiO2-NPs characterization 
Physicochemical properties (e.g. size, charge and surface charge) of NPs have been 
recognized as determinant factors on their potential to elicit biological responses (Zhu et al., 
2012). The highly soluble zinc oxide nanoparticles (ZnO-NPs), for example, elicit heightened 
cellular toxicity response when compared with insoluble TiO2-NPs (Xia et al., 2008). Thus, it 
is pivotal to determine the physical characterization of TiO2-NPs prior to investigating their 
effect on the HMVEC, our biological system model. In this study, commercially available 
spherically shaped TiO2-NPs (Aeroxide P25) from Evonik Degussa (Figure 4.1). Primary 
size of the NPs derived from the TEM micrographs was registered at 23.47 ± 6.1 nm, further 
confirming that these NPs were indeed in the nano size range. The NPs is hydrophilic 
(Creutzenberg, 2013) with surface area of 50 ± 15 m
2
/g (Zhou et al., 2012). The NPs are 




formed with crystalline composition of 73-85% anatase phase, 14-17% rutile phase and 2-
13% amorphous phase (Ohtani et al., 2010; Setyawati et al., 2013b).  
 
 
Figure 4.1: Characterization of TiO2-NPs. Transmission electron microscope (TEM) 
micrograph of TiO2-NPs. Scale bar = 50 nm.  
 
In order to have a more accurate representation of the physical properties of TiO2-NPs 
while interacting with the endothelial cells, hydrodynamic characterization was performed 
using dynamic light scattering (DLS) method prior to in vitro testing. The result suggests that 
in aqueous environment, the TiO2-NPs aggregates with approximate diameter of 300 nm 
(Table 4.1). Nevertheless, when complex cell culture medium was used for dispersion, TiO2-
NPs were observed to form smaller aggregates, with average diameter of 57.1 ± 2.1 nm 
(Table 4.1).  Significant hydrodynamic size reduction was also observed in other studies. Xia 
et al. (2008) reported smaller hydrodynamic size of TiO2-NPs in cell culture medium 
(approximately 294 nm in size), when compared to their size in ultrapure water (691 nm). 
Similar findings have been observed for the case of ZnO, TiO2, and hydroxyapaptite (HA) 
NPs (Ng et al., 2011; Tay et al., 2014b). This significant reduction in TiO2-NPs’ 
hydrodynamic size could be attributed to the serum in the cell culture medium. Serum is 




known to rapidly bind to the NPs and form a protein corona around the NPs (Lundqvist et al., 
2008), which further disperses NPs by providing steric hindrance and electrostatic repulsion 
between the NPs (Ji et al., 2010). In addition, the complex protein environment prompts 
oxide-NPs to shed off some of the materials and further etch the aggregates back to its 
smaller constituent particle sizes (Hanagata et al., 2011).  
The formation of colloid aggregates is also greatly influenced by the ionic strength of the 
solvent. This ionic effect strength was observed when we attempted to prepare the TiO2-NPs 
necessary for the in vivo study, which will be described in greater detail in Chapter 6. The 
measured size of TiO2-NPs was registered to be approximately 2.2 µm when in phosphate 
buffered saline (PBS) (Table 4.1).  It has been suggested that at high electrolyte environment 
such as the PBS solution, the counter-ion clouds that compensate the NPs’ surface charge is 
compressed near the surface of the particle. This makes the electrical repulsion decrease 
considerably while the van der Waals attraction becomes the dominating power. As a result, 
particles agglomerate significantly (Ji et al., 2010; Lundqvist et al., 2008). Ji and coworkers 
(2010) reported that both FBS and bovine serum albumin (BSA) alike could be used to 
disperse NPs. Thus, BSA was introduced into the PBS solution to improve dispersion, as 
evidenced by the reduction in overall hydrodynamic size of the TiO2-NPs comparable with 
those dispersed in cell culture medium (Table 4.1).   
The protein adsorption on the surface of the NPs could be observed through the 
change in ζ-potential reading (Table 4.1). Pristine TiO2-NPs in ultrapure water were 
observed to carry a positive charge (+25.1 ± 2.36 mV) while those dispersed in cell culture 
medium and BSA-supplemented PBS solution carried negative charge with the range of ‒11 
to ‒14 mV. Similarly, TiO2-NPs were reported with initial ζ-potential of +30 mV (in 
ultrapure water) and later on adopted the protein charge after protein adsorption on the NPs 
surface, registering a final ζ-potential of ‒10 mV (in cell culture medium) (Ji et al., 2010).  




Table 4.1: Summary of hydrodynamic characterization of TiO2-NPs 
Dispersant Hydrodynamic size (nm)
*
 ζ-potential (mV)* 
Ultrapure Water 292.7 ± 24.6 + 25.1 ± 2.36 
Complete EndoGro™ 
cell culture medium 
57. ± 12.1 ‒11.6 ± 0.75 
PBS 2777.3 ± 191.5 ‒24.3 ± 0.25 
1% BSA / PBS 44.2 ± 1.3 ‒14.5 ± 0.67 
3% BSA / PBS 44.5 ± 1.3 ‒13.8 ± 0.72 
*
Data are means ± s.d. from three independent measurements. 
 
As bulk TiO2 material was also employed as control both in in vitro and in vivo studies, 
the material was characterized and reported as follows. The TEM micrograph in Figure 
A1.1A showed particles in spherical shape with primary diameter in submicron range (394.7 
± 73.8 nm). DLS measurement (Figure A1.1B) of the TiO2 microparticles (TiO2-MPs) 
registered the mean hydrodynamic diameters of approximately 680 nm and 670 nm, in 
complete cell culture and 1% BSA-supplemented PBS, respectively. The pristine particle’s ζ-
potential was recorded at ‒23.6 mV. Measurement conducted in complete cell culture 
medium and BSA supplemented PBS solution for the TiO2-MPs gave out ζ-potential readings 
of ‒11.7 and ‒14.1 mV, respectively (Figure A1.1B). Despite the diametrically different ζ-
potential values of TiO2-NPs and TiO2-MPs in pristine condition, DLS measurement 
registered similar ζ-potential readings for these materials in both complete cell culture and 
BSA-supplemented buffer (Table 4.1, Figure A1.1B). The similarity of ζ-potential reading 
suggests that any differential biological response that we observed is caused by the 
significant size difference between TiO2-NPs and TiO2-MPs. 
 
 




4.1.2. TiO2-NPs induce the in vitro endothelial cells leakiness 
As mentioned in Chapter 2, the main function of endothelial cells is to provide selective 
barrier for any substance to cross the blood vessel. As such, the structural integrity of the 
endothelial cell barrier is highly important for their physiological function. Thus, the first 
approach of this study was to investigate whether TiO2-NPs would exert any damaging effect 
on the integrity of the endothelial cell barrier. In order to address this question, endothelial 
cells were grown to confluence to allow formation of an intact monolayer barrier prior to any 
treatment. In addition, immunofluorescence technique was employed to facilitate visual 
observation of the TiO2-NPs effects on endothelial cell barrier integrity. The untreated 
endothelial cells were observed to form an intact monolayer. However, this intact monolayer 
of endothelial cells was disrupted when the cells were exposed to TiO2-NPs (10 – 1250 µM), 
as evidenced by the intercellular gaps between the adjacent endothelial cells (Figure 4.2, 
Figure A1.2). The gaps were detected within 30 minutes of TiO2-NPs exposure (Figure 4.2, 
Figure A1.2) and these gaps were prominently observed on the endothelial cell monolayer 
even after over 60 minutes of TiO2-NPs exposure (Figure 4.2, Figure A1.3).  Interestingly, 
no observable disruption was observed on endothelial cell monolayer that was exposed to 
TiO2 microparticles (TiO2-MPs; 400 nm) at the same dosages and exposure duration (Figure 
4.2, Figure A1.4), suggesting that this inducement of endothelial cell barrier leakiness to be a 
size-specific event.  
 
 




Figure 4.2: TiO2-NPs induce in vitro endothelial cells leakiness as observed with 
immunofluorescence technique. TiO2-NPs induced the disruption of the endothelial cell 
barrier integrity (red arrowheads) within short exposure time (30 minutes). The effect was 
observed to persist for at least 60 minutes of TiO2-NPs exposure. In vitro endothelial cells 
leakiness was observed on a confluent monolayer HMVECs following TiO2-NPs exposure as 
low as 10 µM. Higher magnification windows showed leakiness between the endothelial 
cells. Nevertheless, the effect could not be observed when TiO2-microparticles (TiO2-MPs) 
were employed on the intact monolayer of HMVECs. Visualization was done with 
immunofluorescence whereby AJ protein VE-cadherin was visualized in green and the cell 
nuclei were visualized in blue. Scale bar: 50 µm. The complete set of immunofluorescence 








In order to assess the extent of the disruption on the endothelial cell monolayer, 
Transwell permeability assay was employed. First the endothelial cells were cultured over a 
Transwell insert with 0.4 µm pores until the monolayer barrier was formed. Then, the cells 
monolayer was exposed to various concentration of TiO2-NPs, TiO2-MPs (1250 µM), and 
EDTA (2.5 mM) that were mixed with tracer component, FITC-dextran. The extent of 
endothelial cell monolayer leakiness was determined by measuring the amount of FITC-
dextran penetration through the endothelial cell monolayer. Intact endothelial cell barrier 
limits the penetration of FITC-dextran to a minimum, giving the basal level readout of FITC-
dextran barrier penetration. In contrast, a leaky endothelium barrier obtained after treatment 
with EDTA allows liberal penetration of FITC-dextran. 
Consistent with the previous immunofluorescence observation, dose dependent increase 
of FITC-dextran penetration was discerned following the introduction of TiO2-NPs onto the 
endothelial cell monolayer. An approximately 3-fold increase in FITC-dextran penetration 
level was detected after short time exposure (30 minutes) with 1250 µM TiO2-NPs. The 
increased FITC-dextran penetration suggests that the endothelial cell barrier integrity was 
compromised by exposure to TiO2-NPs (Figure 4.3). Introduction of TiO2-MPs to the 
endothelial cell monolayer did not result in an increased level of FITC-dextran penetration 
(Figure 4.3). This indicates that TiO2-MPs caused no disruption of the endothelial cell 
monolayer, corresponding well with our immunofluorescence observation (Figure 4.2, 
Figure A1.4).  
 





Figure 4.3:  TiO2-NPs induce dose dependent in vitro endothelial cells leakiness as 
observed with Transwell permeability assay. Semi-quantitative Transwell assay showed 
increased amount of FITC-dextran in the basolateral portion of the Transwell chamber 
following HMVECs exposure to various concentrations of TiO2-NPs (30 minutes). Increase 
in FITC-dextran permeability suggests the leakiness in endothelial cell monolayer. The 
increased permeability in Transwell assay could not be observed for cells exposed to 1250 
µM of TiO2-MPs (micro). EDTA (2.5 mM, 10 minutes) was used as positive control.  Data 
are means ± s.d., n=3. One way ANOVA with Tukey’s HSD post-hoc test, compared to 
untreated control,*p<0.05 
 
The data from both immunofluorescence and Transwell permeability assay support the 
notion that the leakiness on endothelial cell monolayer is highly dependent on the size of the 
materials exposed to the cells. Both nano- and micro-TiO2 was built from the same material 
chemistry. In addition, they share similar surface charge due to the protein corona formation 
on the surface (Table 4.1 and Figure A1.2). Hence, the only discernable difference in size 
between the two materials becomes the predominant physicochemical property that 
determines their capability to disrupt the integrity of endothelial cell barrier.  
In order to strengthen our notion of size dependency effect of the material, two other 
known NPs of comparable size to TiO2-NPs and their bulk counterparts were tested. SiO2-
NPs (15 nm) and Ag-NPs (20 nm) were capable to disrupt the intact endothelial cell barrier in 
a dose dependent manner. This is evident from the elevated level of FITC-dextran penetrating 




the barrier, which reached approximately 2-fold increase for both types of NPs (Figure 
4.4A). In contrast, their bulk counterparts, SiO2-MPs (500 nm) and Ag-MPs (300 nm) did not 
induce any disruption of the monolayer barrier (Figure 4.4B). The disruption of the 
endothelial cell monolayer seems to be consistently caused by the NPs but not by their bulk 
counterpart (Figure 4.2 - 4.4). As such, this monolayer disruption was coined as 
nanomaterials-induced endothelial cells leakiness (NanoEL).  Overall, the data suggest that 
endothelial cell leakiness is highly dependent on the size of the materials, wherein materials 
in nano-size range were proven to be potent inducers of leakiness.  
 
Figure 4.4: TiO2-NPs, SiO2-NPs and Ag-NPs induce dose dependent in vitro endothelial 
cell leakiness as observed with Transwell permeability assay. Semi-quantitative Transwell 
assay showed that (A) TiO2-NPs (23.5 nm), SiO2-NPs (15 nm) and Ag-NPs (20 nm) could 
induce leakiness of the endothelium monolayer. (B) However, this leakiness could not be 
observed when the endothelium monolayer was exposed to bulk materials: TiO2-MPs (400 
nm), SiO2-MPs (500 nm), and Ag-MPs (300 nm). Data are means ± s.d., n=3. One way 
ANOVA with Tukey’s HSD post-hoc test, compared to untreated control, *p<0.05. 
 
4.1.3. NanoEL is independent of apoptosis  
Intercellular gaps and profound leakiness on the endothelium monolayer are the 
highlights of endothelium barrier breakdown. This barrier breakdown could be attributed to 
apoptosis that occur in the endothelial cells, the building block of the monolayer barrier 
(Alluri et al., 2014; Eruslanov and Kusmartsev, 2010).  One of the most prominent signatures 




of an apoptotic cell is cell shrinkage (Ameisen, 2002). In the network of the endothelium 
barrier, apoptotic event could well result with endothelial cells detaching from their 
neighboring cells, forming intercellular gaps on the barrier. Moreover, NPs have been 
reported to be able to activate cellular apoptosis pathways (Ng et al., 2011; Ye et al., 2010). 
Hence, upon observing NanoEL on the endothelium barrier, it became necessary to ascertain 
the involvement of apoptosis in the initiation of NanoEL.  
As shown in Figure 4.5, TiO2-NPs effect on the endothelial cells viability has been 
minimal at best. No appreciable change in the cell viability was observed following TiO2-NPs 
treatment. The viable cell count remained high (>90% population) even when the treatment 
reached 48 hours (Figure 4.5A). The low cytotoxicity observed in this study was also 
reported in few other studies. Xia et al. (2008) did not detect any adverse effect of TiO2-NPs 
(600 µM) on RAW264.7 and BEAS-2B. Foreskin fibroblast cells’ (BJ cells) cell viability 
count remained high upon exposure to TiO2-NPs (100 µg/mL or equivalent to 1250 µM) for 
24 hours (Setyawati et al., 2013b). Studies suggest that the cytotoxicity of TiO2-NPs only 
manifest at very high concentrations. For example, cytotoxicity of human buccal epithelial 
and human intestinal epithelial cells was detected only at the level of 0.25 - 1 g/L (ca. 3 - 12.5 
mM) (Giovanni et al., 2014). 
 




Figure 4.5: NanoEL is independent of apoptosis. (A) Cell viability was not affected even 
after prolonged TiO2-NPs treatment. Cells were treated with 0.2% Triton X-100 to serve as 
positive control. Graded shaded triangles represent increasing TiO2-NPs exposure duration of 
0, 0.5, 1, 3, 6, 9, 12, 24 and 48 hours. Red dotted line indicates the 90% cell population 
benchmark. Data are means ± s.d., n=3. One way ANOVA with Tukey’s HSD post-hoc test, 
compared to untreated control, *p<0.05. (B) Immunoblotting analysis showed no activation 
of apoptosis over various concentrations of TiO2-NPs and time points.  
 
 
In addition, there was no sign of activation of apoptosis after endothelial cells received 
TiO2-NPs treatment. No cleavage was observed for poly(ADP-ribose) protein (PARP) and 
intrinsic- and extrinsic-mediated apoptosis markers caspase-9 and caspase-8, respectively 
(Figure 4.5B). Most importantly, the protein effector of the apoptotic pathway, caspase-3, 
was detected in its inactive form (Figure 4.5B). The non-cleavage of apoptosis markers 




means that the apoptosis pathway was not activated on TiO2-NPs treated endothelial cells, 
which correlates well with the observed cell viability. Taking this high cell viability and non-
activation of the cellular apoptosis pathway observed in this study, apoptosis was excluded as 
the cause of NanoEL.  
 
4.1.4. NanoEL is independent of oxidative stress 
Another plausible cause of endothelium break down, as highlighted by the presence of 
intercellular gaps on the endothelium and increased leakiness, is oxidative stress. Oxidative 
stress condition mediated by ROS could activate a myriad of intercellular signaling pathways 
and result in barrier breakdown (Lum and Roebuck, 2001). Moreover, Apopa et al. (2009) 
reported the involvement of iron oxide-NPs in inducing oxidative stress and endothelium 
break down. The authors observed significant increase of intracellular ROS, resulting in 
cytoskeletal remodeling and a leaky endothelium. Hence, the capability of TiO2-NPs to 
induce NanoEL via regulation of intracellular ROS was investigated. 
Here, the expression of intracellular ROS in the TiO2-NPs treated endothelial cells was 
screened over a series of exposure time ranging from 30 minutes to 24 hours. In order to 
achieve this, the endothelial cells treated with TiO2-NPs were exposed to DCFH-DA, a cell 
permeable, non-fluorescent probe. Upon internalization by cells, DCFH-DA acetate groups 
are cleaved by the intracellular esterases to produce cell membrane impermeable, non-
fluorescent product, H2DCF. Under the oxidative environment of the cells the H2DCF are 
further oxidized to produce a highly fluorescent molecule, 2’,7’- dichlorofluorescein (DCF). 
Therefore, any changes to the cell oxidative status can be monitored through the measured 
fluorescence signal intensity (Eruslanov and Kusmartsev, 2010).   
As depicted in Figure 4.6, the production of intracellular ROS on TiO2-NPs treated 
endothelial cells, in which intracellular ROS production was elevated by 30% to 70% 




following TiO2-NPs exposure for 24 hours. The result is in good agreement with previous 
studies documenting ROS production induced by TiO2-NPs. Xue et al. (2010), for example, 
recorded that P25 TiO2-NPs, which was used in this study, induced approximately 60% 
increase in intracellular ROS production of HaCaT cells. Similarly, no change in the cellular 
redox environment could be detected in BEAS2B and RAW264.7 cells following TiO2-NPs 
treatment (Xia et al., 2008).   
Figure 4.6: NanoEL is independent of ROS formation. Significant increase on the 
intracellular ROS production level was only detected on cells treated with TiO2-NPs later 
than the 30 minutes when NanoEL was observed. Cells treated with H2O2 (200 μM, 2 hours) 
served as positive control. Graded shaded triangles represent increasing TiO2-NPs exposure 
duration of 0, 0.5, 1, 2, 4, 8, 12 and 24 hours. Data are represented as means ± s.d., n=3. One 
way ANOVA with Tukey’s HSD post-hoc test, compared to untreated control *p<0.05.  
 
More importantly, significant increase in ROS production was only being detected after 
12 to 24 hours TiO2-NPs exposure (Figure 4.6). This well surpassed the 30 minutes exposure 
time with TiO2-NPs wherein NanoEL is initially observed (Figure 4.2), suggesting that ROS 
production and oxidative stress cannot be the perpetrator of the observed NanoEL.  
 
 




4.1.5. NanoEL is independent of cellular uptake 
NPs uptake into the cells has been always considered as a prerequisite for NPs to induce 
biological responses (Gratton et al., 2008; Jiang et al., 2008). Though it is widely accepted, 
this paradigm might not be applicable in this study. The postulation was made by considering 
the fact that the NPs internalization process, like other cellular process, requires time. Murine 
osteoblast  cells (MC3T3-E1) required 6 hours to internalize significant amount of Au-NPs 
with primary size of 12 nm (Mustafa et al., 2011). A single SiO2-NP (50 nm) requires 4 hours 
to enter human capillary microvascular endothelial cell (hCMEC/D3) (Ye et al., 2013). Brun 
et al. (2012) reported 4 hours as the minimum time required for P25 TiO2-NPs to enter rat 
brain endothelial cells. Though varying with the size of the NPs and the cells, the studies 
confirm that a certain extent of time is required to accomplish NPs internalization. It is 
worthy to note that the NanoEL was observed within a short duration of 30 minutes. Taking 
all these considerations, it was hypothesized that the trigger of the observed NanoEL might 
be extracellular.   
In order to investigate the hypothesis, TiO2-NPs were covalently conjugated with 
fluorescence probes, fluorescein isothiocyanate (FITC). This strategy allowed the 
internalization of TiO2-NPs into endothelial cells to be monitored. TiO2-NPs uptake by 
endothelial cells was observed to be time dependent, with significant internalization 
occurring 3 hours after exposure (Figure 4.7A). This was noticeably far later than the 30 
minutes where NanoEL can be first observed (Figure 4.2-4.4). Using FITC-TiO2-NPs, TiO2-
NPs internalization was quantified and their cellular distribution in endothelial cells was 
determined. At the time scale of NanoEL, the majority of the FITC signals were observed to 
be originated from the membrane fraction of the cells (Figure 4.7B). The membrane bound 
TiO2-NPs suggest that these NPs remain outside of the cells and have not been internalized 
fully.  




However, it was noted that the cytosolic fraction of endothelial cells also gave 
fluorescence signal, suggesting that TiO2-NPs marginally present inside the cells. In order to 
be able to conclusively rule out the involvement of NPs internalization in NanoEL and 
validate the working hypothesis, endocytosis inhibitors were employed to block 
internalization of TiO2-NPs into the cells. Here, monodansylcadaverine (MDC) and methyl-
β-cyclodextrin (MβCD) were employed to inhibit NPs uptake via clathrin- and caveolin- 
dependent endocytosis, respectively.  
Interestingly, the immunofluorescence results revealed that 50 µM of TiO2-NPs induced 
NanoEL on the monolayer endothelial cells even when the cells were pretreated with the 
endocytosis inhibitors (Figure 4.7C). Similarly, NanoEL was prominent when cells were 
pretreated with 250 µM of TiO2-NPs instead (Figure 4.7E). Control experiments suggest that 
the endocytosis inhibitors were effectively blocking the internalization of TiO2-NPs. There 
was significant reduction of overall fluorescence signals upon introduction of the endocytosis 
inhibitors to the endothelial cells (Figure 4.7D and F). Collectively, the results strongly 
support the working hypothesis that the internalization of TiO2-NPs is not essential for 
NanoEL initiation. This indicates that the potential cause of NanoEL must have occurred 









Figure 4.7:  NanoEL is independent of TiO2-NPs endocytosis.  (A) Significant endocytosis 
of FITC-TiO2-NPs (1250 µM) was observed after 180 minutes, which was much later than 
the onset of NanoEL (30 minutes, Figure 4.2). Scale bar: 25 µm. (B) FITC signals indicated 
that TiO2-NPs were mainly present on the membrane fraction of endothelial cells. Cells were 
treated with 250 μM of FITC-TiO2-NPs and the reading was normalized to cytosolic fraction 
at t=0. Data are means ± s.d., n=3. One way ANOVA with Tukey’s HSD post-hoc test, 
compared to corresponding cytosolic sample #p<0.05; compared to t=0 control, *p<0.05. (C-
F)  Blocking NPs internalization with inhibitors did not prevent NanoEL. Scale bar: 50 µm. 
Data are means ± s.d. of n=3. One way ANOVA with Tukey’s HSD post-hoc test, compared 
to no-inhibitor control, *p<0.05.  





Here, a size dependent disruption of endothelial cell monolayer barrier was discovered. 
Materials in nano size range were found to potently induce leakiness of the endothelial cell 
monolayer in contrast to their bulk counterpart. Size has been recognized as one of the 
deterministic factors on the capability of materials to elicit biological responses (Zhu et al., 
2012). HeLa cells were reported to uptake the spherical Au-NPs in a size dependent manner, 
with 50 nm being the critical size for optimal uptake (Chithrani et al., 2006). Comparative 
study between nano TiO2 (20 - 70 nm) and micron size TiO2 (128 - 949 nm) showed that 
nano TiO2 is acutely toxic to zebra fish whereas micro size TiO2 are non-toxic (Xiong et al., 
2011). Similarly, TiO2-NPs were reported to induce higher induction level of apoptotic event 
leading to enhanced JB6 cells cytotoxicity when compared to the fine particulates (Zhao et 
al., 2009). Though widely accepted as one of the determinants of material induced biological 
response, size has never been linked as the cause of NanoEL described in this study. The 
study findings on size dependent NanoEL further exemplify the need to better understand the 
NMs’ physiochemical properties when assessing possible nano-bio interactions.  
Contrary to majority of nano-bio interaction studies mainly focusing on NMs induced 
cell death, it was noted that the damaging effect of NMs interaction with biological system 
does not always manifest with cell death. Endothelial cells retained their cellular health after 
TiO2-NPs exposure, but lost their ability to maintain monolayer integrity. Similarly, no 
apparent cytotoxicity was observed on human buccal epithelium (TR146) over a broad range 
of TiO2-NPs, SiO2-NPs, and HA-NPs exposure. Yet, these NPs induced massive disruption of 
the cellular microtubule network, significantly reducing capabilities of cell migration and 
wound healing (Tay et al., 2014a). Likewise, Singh et al. (2014) discovered that carbon 
nanotubes could cause endothelial cells to loss their polarity and orientation bias without any 
cytotoxicity effect being detected. Collectively, these results highlight that NMs safety 




assessment focusing on cell death is not sufficient to capture the full extent of nano-bio 
interaction and its possible outcome. The new nanotoxicity assessment paradigm, as 




In summary, it was observed that nanomaterials but not bulk materials could induce 
leakiness on an otherwise intact monolayer of endothelial cells. This leakiness, which was 
coined as nanomaterials induced endothelial cells leakiness (NanoEL), was observed 
following a short span of NPs exposure. Two cellular processes, ROS upregulation and 
apoptosis event, were excluded as the cause of the observed NanoEL. In addition, it was 
found that the observed NanoEL did not require the internalization of NPs. Thus, it raises the 

















In the previous chapter, nano-sized materials embodied by TiO2-NPs have been shown to 
induce endothelial cells leakiness (NanoEL) independent of any intracellular events such as 
apoptosis and oxidative stress. It also has been demonstrated that the initiation of NanoEL is 
independent of TiO2-NPs internalization. However, the exact mechanism of NanoEL 
induction is still largely unknown. As disruption in the endothelium barrier has been 
attributed to several pathologies such as cancer metastasis and progression (Hashizume et al., 
2000), edema and diabetic retinopathy (He and King, 2004), uncovering the mechanism of 
how NanoEL induction would provide significant biological significance. In addition, in-
depth understanding of the nature of nano-bio interaction will allow us to reduce the potential 
of nano-induced vascular pathology. 
This chapter contains the effort to understand the nature of NanoEL induced by TiO2-
NPs. Here, the nano-bio interaction responsible for initiating NanoEL was identified. In 
addition, the downstream cellular cascade triggered by the initial interaction between TiO2-
NPs and its partner was mapped out.  
 
5.1. Results 
In order to have the full picture on how NanoEL occurs, it is necessary to first identify 
TiO2-NPs interacting partner. As such, we turned to the data that we have gathered thus far 
for some clue. As early NanoEL is independent of endocytosis (Figure 4.7), it was postulated 
that the interaction of TiO2-NPs and their partner that induces NanoEL occurs on the exterior 
part of the endothelial cells. Moreover, size of the nanomaterials plays a major deterministic 
factor on the NanoEL induction (Figure 4.2 – 4.4). This suggests that size might play a role 
in limiting the interaction responsible for NanoEL, probably due to the size constrictive 
nature of the environment where the interaction occurs.  




In addition, we considered the known biology of the endothelial cells and casted VE-
cadherin as the TiO2-NPs possible “partner in crime”. VE-cadherin involvement in NanoEL 
was suggested due to these following reasons. First, VE-cadherin is a transmembrane protein 
with both extracellular and intracellular domains. Moreover, VE-cadherin extracellular 
portion is responsible for maintaining endothelial cell barrier integrity by forming homophilic 
interactions between neighboring cells. More importantly, this homophilic interaction occurs 
in the nano-size space of AJ, which is approximately 22.5 nm based on the minimum length 
formed by homophilic interaction of cadherin complex (Leckband and Prakasam, 2006). It 
was then hypothesized that TiO2-NPs may migrate into this AJ and directly interact with the 
VE-cadherin at the AJ, with the end result of disruption of the endothelial cell barrier 
integrity. 
 
5.1.1. TiO2-NPs directly bind to VE-cadherin  
The possibility of TiO2-NPs directly interact with VE-cadherin was tested by taking the 
working principle of immunoprecipitation wherein interaction between two proteins could be 
determined by isolating one protein and detecting the presence of its interacting partner in the 
isolate. Utilizing the same principle, Deng et al. (2011) reported the association between gold 
nanoparticles (Au-NPs) and fibrinogen by isolating the Au-NPs post-exposure and detecting 
the presence of fibrinogen in the pool of protein eluted from the Au-NPs.  
In a similar manner, TiO2-NPs were made use as the precipitation agent. If VE-cadherin 
indeed interacted with TiO2-NPs, its presence could be detected in the TiO2-NPs isolate. It 
was observed that the amount of VE-cadherin precipitated with TiO2-NPs was increased with 
the increased TiO2-NPs concentration exposed to the cells (Figure 5.1).  In contrast, no 
treatment control (C) and agarose beads (A), which were added to check unspecific binding 
between TiO2-NPs and VE-cadherin, did not pull down any detectable VE-cadherin (Figure 
5.1).  






Figure 5.1: TiO2-NPs directly bind to homophilic VE-cadherin in the AJ as observed 
with TiO2-NPs pull-down assay. The presence of TiO2-NPs pulled down VE-cadherin in a 
dose dependent manner. Post-lysis (P) addition of TiO2-NPs (1250 µM) to a non-treated 
control did not pull down any detectable VE-cadherin. This suggested that an intact AJ is 
important for TiO2-NPs to bind to VE-cadherin and demonstrated that TiO2-NPs bind to VE-
cadherin within the AJs and not in the lysis buffer conditions. Protein A Agarose beads (A) 
were added to show that no detectable VE-cadherin were precipitated in the absence of TiO2-
NPs. Whole cell lysate showed similar expression of VE-cadherin across the various groups 
indicating that TiO2-NPs did not affect cellular VE-cadherin expression transcriptionally or 
post-translationally. Schematic cartoon (Scheme 3.1) showing the experimental setup could 
be found in Chapter 3. Immunoblot image is representative of three different experiments. 
 
In addition, we also wanted to determine the importance of intact AJ (a priori condition 
for an intact cell junction) in facilitating the TiO2-NPs interaction with VE-cadherin. In 
addition to that, we wanted to rule out the possibility that VE-cadherin and TiO2-NPs binding 
had occurred in the lytic condition. As such, a post-lysis group (P), where cells were first 
lysed and protein extracts were added with TiO2-NPs, was introduced into the existing 
treatment groups. There was no evident VE-cadherin being pulled-down in the P group, 
suggesting that the natural arrangement and homophilic interactions of VE-cadherin within 
the AJ is necessary for the binding between TiO2-NPs and the VE-cadherin to occur (Figure 
5.1).  
In contrast, endogeneous intracellular proteins like SOD1 and α-tubulin were not found 
to be associated with TiO2-NPs (Figure 5.1). This is in agreement with the working 




hypothesis that an external stimulus triggers NanoEL. Interestingly, the tight junction protein 
claudin-5 found in the inter-endothelial niche was not pulled down by the TiO2-NPs (Figure 
5.1), suggesting specificity of TiO2-NPs towards VE-cadherin.   
To further prove the physical interaction between TiO2-NPs and VE-cadherin, in situ 
proximity ligation assay (PLA), which normally is utilized to detect protein-protein 
interaction, was adapted. First, the TiO2-NPs were conjugated with mouse IgG through 
silanization process and subsequent crosslinking (Scheme 3.2). Here, glutaraldehyde allows 
conjugation of the IgG Fab region onto the TiO2-NPs surface. This leaves the IgG Fc region to 
protrude out of the NPs (Kumar et al., 2011), allowing recognition by the PLA secondary 
antibody probe.  
Through this modified PLA protocol (Scheme 3.3), TiO2-NPs were observed to 
physically interact with VE-cadherin (< 40 nm apart), as determined from the positive PLA 
signals along the AJs region (Figure 5.2A). Additionally, the physical interaction between 
TiO2-NPs and VE-cadherin increased accordingly with the increasing amount of TiO2-NPs, 
presumably due to more TiO2-NPs found their way onto the AJ (Figure 5.2 B). In order to 
give further evidence of the distance sensitivity of PLA, a non-interacting protein control 
group was introduced by way of probing for interaction between VE-cadherin and actin. 
Though they are close to each other, both proteins are separated by the catenin complexes 
(Dejana, 2004). As predicted, there was no observable positive PLA signal from the non-
interacting control group (Figure 5.2). 
 







Figure 5.2: TiO2-NPs directly bind to homophilic VE-cadherin in the AJ as observed 
with TiO2-NPs in situ proximity ligation assay (PLA). (A) Direct interaction between 
TiO2-NPs and VE-cadherin was assessed with modified PLA (Scheme 3.3). Intact monolayer 
of endothelial cells was treated with mouse-IgG conjugated TiO2-NPs for 30 minutes. 
Through the PLA protocol, red fluorescence signals were observed following mouse IgG-
TiO2-NPs treatments (100 and 250 µM) to indicate direct interaction. Untreated, nanomaterial 
nonspecific, and non-interacting proteins (Primary Antibodies: VE-cadherin + Actin) controls 
all showed negative signals. Scale bar: 50 µm. (B) Quantification of red signals showed 
increased TiO2-NPs interaction with VE-cadherin with increasing dose of TiO2-NPs. Data are 
means ± s.d., n = 3, One way ANOVA with Tukey’s HSD post-hoc test, compared to 
untreated control, *p<0.05. VEC = VE-cadherin; ACT = actin.  




5.1.2. TiO2-NPs induce the declustering of homophilically interacted VE-cadherin 
As previously described, VE-cadherin maintains the integrity of the endothelial cell AJs 
by making pericellular zipper-like form of homophilic interacted VE-cadherin clusters in 
between the neighboring endothelial cells (Dejana, 2004). Since, TiO2-NPs were observed to 
interact with VE-cadherin (Figure 5.1-5.2), we then asked whether this TiO2-NPs and VE-
cadherin physical interaction could affect the VE-cadherin clusters and result in NanoEL.  
 To determine whether TiO2-NPs could cause disruption of homophilically clustered 
VE-cadherin, an immunoblotting technique from Huang et al. (2011) was adopted. The 
authors utilized the technique to show disruption of VE-cadherin clusters by Angiopoietin-
like 4 protein (ANGPTL4). Through specific immunoblotting for the VE-cadherin molecule 
separated under native protein conditions, we showed that there was declustering of 
homophilically clustered VE-cadherin in the TiO2-NPs treated groups (Figure 5.3) but not in 
the TiO2-MPs (micro) group (Figure 5.3). The positive control group for endothelial cell 
leakiness, as determined using EDTA treatment, confirmed the electrophoretic apparent size 
of disrupted native VE-cadherin (Figure 5.3). The untreated control group also helped 
calibrated the electrophoretic apparent size of the homophilically interacted pairs of VE-
cadherin on the native gel (Figure 5.3). This suggests that TiO2-NPs might have initiated 
NanoEL by disrupting the homophilically clustered VE-cadherin.  
 
Figure 5.3: TiO2-NPs cause the disruption of VE-cadherin clusters. Non-denaturing 
native gel electrophoresis probed for VE-cadherin showed clustered and declustered forms of 
VE-cadherin. TiO2-NPs treatment induced declustering of VE-cadherin while TiO2-MPs 
(micro) treatment did not. EDTA (2.5 mM, 10 minutes) is a positive control for declustered 
VE-cadherin. Immunoblot image is representative of three different experiments. 




5.1.3. TiO2-NPs trigger activation of VE-cadherin pathway  
Through the physical binding of TiO2-NPs to VE-cadherin (Figure 5.1–5.2) that causes 
the disruption on VE-cadherin clusters (Figure 5.3), the initial trigger of NanoEL could be 
identified. However, these only partially explain the NanoEL phenomenon, as disruption on 
the VE-cadherin clusters alone could not account for the micron-size gaps observed in 
NanoEL (Figure 4.2). In canonical endothelial monolayer permeability, these micron-size 
gaps could be observed following the activation of an actin rearrangement pathway mediated 
by VE-cadherin and triggered by external stimulus (e.g. vascular endothelial growth factor 
(VEGF) and histamine).   
The key to regulation of cell shape and endothelial monolayer permeability is held by 
the cadherin–catenins–actin ternary complex (Dejana, 2004), where β-catenin and p120 
proteins play an intermediary role to link the perimembranous actin and VE-cadherin 
(Dejana, 2004; Dejana et al., 1999). These intermediary proteins are docked at the VE-
cadherin intracellular domains, at the sites of Tyrosine 658 (Y658) and Tyrosine 731 (Y731). 
As such, external stimuli such as VEGF and histamine that induce phosphorylation at these 
residues can cause the loss of VE-cadherin interaction with the p120 and β-catenin (Adam et 
al., 2010; Andriopoulou et al., 1999; Gavard and Gutkind, 2006). Consequently, this would 
trigger the actin remodelling pathway and cause internalization and degradation of VE-
cadherin. The activation of these pathways results in cell shape deformation and intercellular 
gaps formation (Dejana, 2004; Xiao et al., 2005). Nevertheless, the mechanism of NanoEL 
was reckoned to be different than the known endothelial monolayer permeability signaling, as 
it is unlikely for endothelial cells to possess a cognate receptor that recognizes a synthetic 
entity like TiO2-NPs. Thus, the canonical signaling of endothelial permeability was taken as a 
guide and to the cellular signaling of NanoEL was compared against, enabling the 
investigation of how these two cellular signaling might coincide. 




a. TiO2-NPs induce VE-cadherin phosphorylation 
VE-cadherin phosphorylation on sites Y658 and Y731 is the first characteristic of 
pathway activation. Thus, the involvement of TiO2-NPs in VE-cadherin phosphorylation at 
sites Y658 and Y731 was studied. Indeed, TiO2-NPs were observed to bring about the VE-
cadherin phosphorylation at the site Y658 and Y731, similar to what was observed for the 
case of endothelial cells treated with VEGF and histamine (Figure 5.4A).  
As VE-cadherin phosphorylation at these specific sites was mediated by Src-kinase 
(Adam et al., 2010; Esser et al., 1998; Gavard and Gutkind, 2006), it was pivotal to further 
examine whether the phosphorylation of VE-cadherin induced by TiO2-NPs was also 
mediated by the Src kinase. The Src-kinase involvement was investigated by pre-treating the 
cells with a Src-kinase inhibitor, PP1. The PP1 successfully inhibited the phosphorylation at 
both sites of VE-cadherin induced by VEGF and histamine (Figure 5.4A). In TiO2-NPs 
treated cells, however, PP1 treatment only repressed VE-cadherin phosphorylation at site 
Y731, while phosphorylation at residue Y658 was not affected (Figure 5.4A).   
To establish the causative relation between VE-cadherin phosphorylation and NanoEL, 
PP1 was utilized and its effect on the NanoEL was investigated. Consistent with the previous 
observation, TiO2-NPs induced leakiness on the intact monolayer endothelial cells. Likewise, 
endothelium barrier integrity was compromised by VEGF and histamine treatments (Figure 
5.4B). As expected, PP1 inhibition of Src-kinase showed a significant reduction of VEGF- 
and histamine-induced endothelial leakiness (Adam et al., 2010; Gavard and Gutkind, 2006), 
at 110% and 120% reduction in leakiness, respectively (Figure 5.4B). In contrast, the PP1 
inhibitor did not induce significant reduction of TiO2-NPs mediated leakiness, with only 30% 
reduction of leakiness (Figure 5.4B). The results suggest that VE-cadherin phosphorylation 
is one of the events required to induce NanoEL. More importantly, these observations 




highlight the possibility that a non-Src kinase might be involved in phosphorylation of the 





Figure 5.4: TiO2-NPs induce phosphorylation of VE-cadherin. (A) TiO2-NPs treatment 
induced tyrosine phosphorylation of VE-cadherin at Y658 and Y731 but may not involve Src 
kinase. TiO2-NPs (250 μM) triggered Y658 and Y731 phosphorylation on VE-cadherin. 
VEGF (V), histamine (H) and EDTA (E) served as control stimulants. Src kinase inhibitor, 
PP1 effectively inhibited VEGF and histamine-induced phosphorylation of VE-cadherin at 
Y658 and Y731. However, TiO2-NPs treatment showed persistent phosphorylation of Y658 
even with PP1 treatment. Immunoblot image is representative of three different experiments. 
(B) PP1 treatment was able to reduce the degree of FITC-dextran flux across the endothelial 
monolayer treated with VEGF and histamine. In contrast, FITC-dextran flux was relatively 
less repressed in endothelial monolayer with PP1 and TiO2-NPs treatment. Data are means ± 
s.d., n=3, One way ANOVA with Tukey’s HSD post-hoc test, *compared to untreated 
control, p<0.05; #compared to no PP1 treatment, p<0.05.  
 




b. TiO2-NPs induce the release of p120 and β-catenin from VE-cadherin 
The VE-cadherin residues Y658 and Y731 hold important roles in maintenance of 
endothelial monolayer barrier integrity, as these residues are the docking sites for p120 and β-
catenin proteins on the VE-cadherin (Dejana, 2004; Dejana et al., 1999). It has been reported 
that the phosphorylation of these residues prevents the binding of p120 and β-catenin proteins 
on VE-cadherin, leading to the increased endothelial cells leakiness (Hatanaka et al., 2011). 
Since TiO2-NPs were found to induce the phosphorylation of these important VE-cadherin 
residues, we then studied whether the TiO2-NPs could also cause the loss of interaction 
between VE-cadherin and either β-catenin or p120 catenin. 
Utilizing immunoprecipitation technique, VE-cadherin was precipitated down and the 
level of its interaction with p120 and β-catenin was determined. The immunoblotting result 
shows there was a significant decrease of β-catenin and p120 being detected when VE-




Figure 5.5: TiO2-NPs treatment induces release of p120 and β-catenin from VE-
cadherin. (A) VE-cadherin showed decreased interaction with β-catenin following TiO2-NPs 
treatment (250 µM). (B) The vice versa immunoprecipitation of β-catenin also showed 
decreased interaction of β-catenin with VE-cadherin (C) Decreased interaction between VE-
cadherin with p120 following TiO2-NPs treatment (250 µM). (D) The vice versa 
immunoprecipitation also show decreased interaction of p120 with VE-cadherin. Immunoblot 
image is representative of three different experiments.  




The vice versa pull down experiment utilizing β-catenin and p120 as precipitation 
agents showed similar trend of decreasing VE-cadherin detected  (Figure 5.5B, D). The 
reduction of β-catenin and p120 eluted from the VE-cadherin immunoprecipitation suggests 
the loss of interaction between VE-cadherin and β-catenin as well as VE-cadherin and p120 
catenin (Figure 5.5).  
 
 
5.1.4. TiO2-NPs induce internalization and degradation of VE-cadherin 
As a result of the loss of interaction between VE-cadherin and the intermediary proteins 
β-catenin and p120, VE-cadherin may become disconnected from the actin filament. 
Unanchored VE-cadherin has been reported to be internalized and degraded, causing the 
further intercellular junction disassembly and endothelial cell leakiness (Gavard and Gutkind, 
2006; Xiao et al., 2005). Therefore, we next investigated whether TiO2-NPs could also cause 
the internalization and degradation of untethered VE-cadherin. BV6, a monoclonal antibody 
that specifically recognizes the extracellular domain of the VE-cadherin, was utilized to study 
the internalization and degradation of VE-cadherin (Gavard and Gutkind, 2006). In addition, 
to differentiate internalized VE-cadherin from those remaining on the cell surface, 
trypsinization was used to remove cell surface proteins while leaving the intracellular protein 
pools intact (Xiao et al., 2003). 
The immunoblotting data suggest that all treatments did not induce any significant 
difference in the total expression of VE-cadherin, as can be seen from the whole cell lysate 
panel on the left hand side of the immunoblots (Figure 5.6A-C). Nonetheless, significant 
increase of VE-cadherin on the intercellular protein pool of trypsinized cells was detected 
following treatment with TiO2-NPs (Figure 5.6A), VEGF (Figure 5.6B) and histamine 
(Figure 5.6C).  




 It was previously reported that VE-cadherin was internalized via clathrin dependent 
pathway following VEGF treatment (Xiao et al., 2005). Thus, the manner of TiO2-NPs 
induced VE-cadherin internalization was probed by employing clathrin endocytosis inhibitor, 
MDC, and depleting potassium ions to inhibit the internalization. With the application of 
these clathrin inhibiting compounds and induction of leakiness, a significant reduction of VE-
cadherin internalization was observed (Figure 5.6A-C). This suggests that TiO2-NPs induce 
internalization of VE-cadherin via clathrin dependent endocytosis.  
In addition to immunoblotting, immunofluorescence was employed to detect VE-
cadherin internalization induced by TiO2-NPs. Instead of trypsinization, acid wash was 
utilized to etch VE-cadherin at the cell surface and allow the detection of internalized VE-
cadherin. Consistent with the immunoblotting result, VE-cadherin was observed being 
internalized following TiO2-NPs treatment (Figure 5.6D). It is worthy to note that through 
the modified PLA assay, the presence of interacting TiO2-NPs and VE-cadherin was detected 
to be further inward of the cell surface (Figure 5.2). This suggests the possibility that TiO2-
NPs bound to VE-cadherin are internalized along with the VE-cadherin during the 
internalization and degradation processes.  
The same techniques were employed to study the degradation process of VE-cadherin 
induced by the leakiness inducing compounds TiO2-NPs, VEGF, and histamine. To 
understand which specific degradation pathway is responsible for TiO2-NPs induced VE-
cadherin degradation, MG132 and chloroquine were employed to inhibit proteosomal and 
lysosomal degradation processes, respectively. The application of chloroquine, but not 
MG132, resulted in increased internalization of VE-cadherin (Figure 5.7A-C). Similarly, the 
immunofluorescence data showed that without chloroquine, TiO2-NPs treatment did not 
result in any detectable VE-cadherin internalization (Figure 5.7D). This suggests that the 
degradation of VE-cadherin predominantly occurs via the lysosomal degradation pathway. 






Figure 5.6: TiO2-NPs induce internalization of VE-cadherin.  (A) Increased amount of 
internalized VE-cadherin was observed following TiO2-NPs treatment. (B) Potassium 
depletion (K depl.) and (C) monodansylcadaverine (MDC) reduced internalization of VE-
cadherin. Immunoblot image is representative of three different experiments. (D) 
Immunofluorescence detected internalized VE-cadherin (red arrowheads) following treatment 
with TiO2-NPs, VEGF or histamine. Meanwhile VE-cadherin was confined to the cell 
boundaries in the control group. The cell periphery is demarcated by the dashed line. Scale 
bar: 15 μm.  
 






Figure 5.7: TiO2-NPs induce degradation of VE-cadherin. (A) TiO2-NPs treatment led to 
the lysosomal degradation of VE-cadherin. (B) Inhibiting the proteasome pathway with 
MG132 did not result in any significant increase in the amount of VE-cadherin. In contrast, 
inhibiting the lysosomal pathway with chloroquine (CHQ) showed an increased stability of 
internalized VE-cadherin was observed with (C) immunoblotting technique. Immunoblot 
image is representative of three different experiments. (D) Confocal image shows stability of 
internalized VE-cadherin (red arrowheads). The cell periphery is demarcated by the dashed 
line. Scale bar: 15 μm.  
 
  




5.1.5. TiO2-NPs trigger activation of actin remodeling to induce NanoEL 
The loss of interaction between VE-cadherin and β-catenin or p120 results in 
disassociation of VE-cadherin from the actin filament. This dissociation between VE-
cadherin and actin filament could result in two consequences: the unanchored VE-cadherin 
becomes prone to internalization and degradation, as shown in section 5.1.4; the untethered 
actin filament triggers the activation of cytoskeleton remodeling.  To study whether the actin 
remodeling pathway is activated and responsible for NanoEL, the cytoskeleton network was 
perturbed, allowing the investigation of its effect on NanoEL.  The perturbation of 
cytoskeleton network was done with pre-treatment with the RhoA kinase (ROCK) inhibitor, 
Y-27632. Since ROCK inhibits F-actin depolymerization through myosin phosphatase and 
cofilin and maintains F-actin stabilization (Maekawa et al., 1999), addition of Y-27632 
destabilizes the F-actin. This causes the reduction of stress fibers formation while cell-cell 
adhesion is maintained, as can be seen from the immunofluorescence data where endothelial 
cell monolayer treated with Y-27632 are shown to maintain their integrity despite lack of 
actin filaments detected (Figure 5.8A). In fact, the Transwell assay data indicated that Y-
27632 treatment improves endothelial barrier function by two-fold, probably due to F-actin 
recruitment to the AJ, where α- and β-catenin are located (Carbajal et al., 2000).  
Approximately 70% reduction in the degree of NanoEL was detected by inhibiting the 
cell capability to remodel the actin filaments. Interestingly, increase of FITC-dextran flux 
even was detected even when the cells have been preconditioned to Y-27632 prior to TiO2-
NPs exposure, albeit to a significantly lesser degree when compared to the untreated Y-27632 
control (Figure 5.8B). Taken collectively, this data suggest that perturbing cell ability to 
remodel its cytoskeleton could help to mitigate NanoEL in some degree, but is insufficient to 
completely inhibit NanoEL from occurring.  
 
 






Figure 5.8: TiO2-NPs induce actin remodelling (A) Treatment with ROCK inhibitor, Y-
27632 for 1 hour, effectively abrogated formation of stress fibers without compromising 
endothelial barrier integrity as shown by the VE-cadherin staining. Scale bar: 20 µm. (B) 
TiO2-NPs activated actin remodeling that led to NanoEL. Y-27632 treatment alone reduced 
inherent endogenous endothelial leakiness in a dose dependent manner and negated TiO2-NPs 
(250 μM) induced leakiness. Data are means ± s.d., n=3, One way ANOVA with Tukey’s 
HSD post-hoc test,
 
#compared to TiO2-NPs treatment, p<0.05. Scale bar: 20 μm. 
 





This study has shown that NanoEL is triggered by the disruption of VE-cadherin clusters 
due to its physical interaction with dense and rigid NMs that find their way into the 
endothelial cells AJs. This initiation of endothelial cell leakiness is markedly different from 
the more recognized mechanism of receptor mediated endothelial cell leakiness, where the 
mediator molecule triggers leakiness by binding to its specific receptor. For example, 
histamine is reported to trigger the leakiness via H1 receptor binding, while VEGF requires 
binding to its receptors, VEGFR-1 and VEGFR-2 to initiate endothelial cell barrier leakiness 
endothelial cell barrier (Komarova and Malik, 2010).  
How the nanoparticle could find its way into the AJs is still largely unknown. 
Considering that the luminal side of the endothelial cell barrier is covered with the negatively 
charged glycocalyx and the NPs themselves carry a negative charge, it should be expected 
that no trace of NPs could be found on the endothelial cells surface let alone inside the AJ. 
However, the result suggest otherwise. It is possible that the repulsion force indeed drive the 
NPs away from the cell surface, however the NPs high mass density makes it settle quickly 
back on the cell surface. In the midst of this repetitive bouncing on and off the cell surface, 
NPs could have bounced and rolled into the AJs and bound to the VE-cadherin clusters. 
Exactly how physical binding of TiO2-NPs to VE-cadherin could disrupt VE-cadherin 
clusters is yet unknown. It is possible that TiO2-NPs bind directly on the site where VE-
cadherin homophilic bond occurs, thus disrupting the homophilic interaction. It is also 
possible that the negatively charge TiO2-NPs binds to the Ca
2+
 ions that mediate the VE-
cadherin homophilic bond, causing the same outcome of disrupted homophilic interaction. 
EDTA was reported to perturb VE-cadherin homophilic interaction by chelating out the Ca
2+
 
ions (Huang et al., 2011). Whichever disruption mechanism it might be, TiO2-NPs have been 
demonstrated to cause mechanical disruption to the VE-cadherin clusters that is sufficient to 




induce a signaling cascade that results in endothelial cell monolayer leakiness. The notion 
that mechanical stress could also play a role in the endothelial cells leakiness is supported by 
a recent study conducted by Dejana’s group. The authors observed that shear stress caused by 
blood flow could cause VE-cadherin phosphorylation and induce vascular leakiness 
(Orsenigo et al., 2012).   
This study also highlights a new possible escape route of NMs from the blood circulation. 
The current precept of NMs transport across cell barriers involves numerous steps of (1) 
endocytosis, (2) intracellular trafficking involving endosomal and lysosomal compartments, 
(3) repackaging into exocytosis vesicles and (4) actual exocytosis that allows the NMs to end 
up at the other side of cell barrier (Monopoli et al., 2012). However, with leakiness induced 
by the NPs, it is highly possible that NPs escape the cell barrier of blood vessel through this 
opening instead. This exodus of NPs through the gaping AJs possibly could cause more NMs 
to escape the blood circulation and deposit in major organs. 
 
5.3. Summary 
In summary, TiO2-NPs interaction with endothelial cells was found to manifest in the 
form of a physical interaction with the AJ protein, VE-cadherin. TiO2-NPs were also found to 
disrupt VE-cadherin clusters presumably due to its direct binding to VE-cadherin. In addition, 
TiO2-NPs were found to induce a cascade of intracellular signaling pathway, starting with 
VE-cadherin phosphorylation and followed by the loss of interaction between VE-cadherin 
and its partners, β-catenin and p120. Subsequent activation of signaling pathways induced 
internalization and degradation of VE-cadherin, and remodeling of the cytoskeleton. These 
two pathways converged in the same outcome of cell shape deformation and intercellular 

















Previous chapters have described how in in vitro setting, NMs could induce leakiness 
of endothelial cell monolayer (Chapter 4) through its physical interaction with the 
endothelial cells AJ protein, VE-cadherin (Chapter 5). Although this in vitro system has 
allowed us to study the NMs interaction with cells, this system is simplistic in nature. This 
brings the question whether the in vitro observation could be observed as well in a much 
more complex system, such as the human body. As such, in vivo mouse studies were 
conducted to provide the necessary validation for the in vitro findings.  
In this chapter, in vivo validation work using the mouse model is described. The 
evidence of the capability of TiO2-NPs to induce vasculature leakiness in an in vivo setting 
was provided through two distinctly different mouse models, the subcutaneous model and 
melanoma metastasis model.   
 
6.1. Results  
6.1.1. TiO2-NPs cause endothelial cell leakiness in subcutaneous blood vessels 
A subcutaneous blood vessel model was employed to obtain direct evidence of TiO2-NPs 
induced leakiness in in vivo setting.  In this model either TiO2-NPs or vehicle buffer was 
directly injected into subcutaneous pockets created in the back of mice. The relatively sparse 
and distinct vascular network on the back of the mice (Figure 6.1A) allowed leakiness to be 
observed directly while reducing the chance of blood vessel damage solely due to injection 
(Huang et al., 2011). Evans blue dye (EBD), an indicator of vasculature leakiness that is 
characteristically bound to albumin, was then injected into the tail vein. As normal functional 
endothelium barrier limits blood albumin penetration, EBD should be normally restricted in 
the blood vessel. Therefore, the leaky vasculature could be identified by detecting the amount 
of EBD-bound albumin being extravasated from the blood vessel into the tissue (Huang et al., 
2011; Radu and Chernoff, 2013).  




TiO2-NPs at a localized dose of 8 µg/kg BW were observed to be sufficient to cause 
increased EBD extravasation at the subcutaneous vasculature on the back of mice (Figure 
6.1A). The quantification of extravasated EBD (Figure 6.1B) shows close to 2.5-fold 
increase of EBD extravasation into the tissue following TiO2-NPs treatment. These results 
indicate that TiO2-NPs can cause vascular leakiness when delivery is localized.  
To date, there is only one other study besides this study that describe NMs induced 
leakiness of the endothelium barrier. Sharma et al. (2010) described that copper (Cu), 
aluminium (Al) and silver (Ag) NPs were able to cause leaky brain endothelium barrier, as 
evidenced by EBD extravasation on the various regions of the rat’s brain. 
 
 
Figure 6.1: TiO2-NPs promote in vivo endothelial cell leakiness in subcutaneous skin 
model. TiO2-NPs were locally injected into subcutaneous pockets on the back of mice while 
tail vein injection was used to introduce EBD into blood circulation. (A) Noticeably more 
EBD extravasation observed in the TiO2-NPs group (8 µg/kg BW dose equivalent to 100 
µM). Scale bar: 1 cm. (B) Quantification of extravasated EBD showed more endothelial 
leakiness in the TiO2-NPs group compared to the untreated mice group. Data are means ± s.d. 
from 3 independent experiments. Student’s t-test, compared to untreated control, *p<0.05.  
  




6.1.2. TiO2-NPs cause endothelial cell leakiness in a mouse lung metastasis model 
In addition to the subcutaneous model, the melanoma metastasis model was utilized to 
investigate the possibility of TiO2-NPs induced vasculature leakiness. The melanoma 
metastasis model was chosen due to several reasons. First, metastasis process requires leaky 
vasculature for cancer cells to intravasate into the blood circulation and to extravasate out to a 
secondary site (Reymond et al., 2013; Valastyan and Weinberg, 2011). Second, in vivo 
studies indicate inhaled, ingested and injected TiO2-NPs are accumulated in major organs 
such as liver, kidney and lung (Fabian et al., 2008; Geiser and Kreyling, 2010; Oberdorster et 
al., 1994; Wu et al., 2010b). These accumulated TiO2-NPs could induce leakiness in the 
endothelium barrier resulting in the aberrantly leaky blood vessels.  As such, it was 
postulated that the leaky vasculature induced by TiO2-NPs may act as the entry or exit points 
for these metastatic tumor cells, facilitating increased cancer colonization at secondary sites.  
The potential effect of TiO2-NPs on vasculature integrity was conducted in two exposure 
schemes. An acute exposure study was conducted to understand the effect of accumulated 
TiO2-NPs towards the vasculature integrity, while sub-chronic exposure was designed to 
understand the effect of prolonged and continuous exposure of NMs on the vasculature 
integrity. Here, an established metastasis model where murine melanoma cells (B16F10) 
were injected into the blood circulation was adopted (Huang et al., 2011; Peinado et al., 2012; 
Stackpole, 1981). These melanoma cells are known for their propensity to metastasize to the 
lung (Lee, 1980). Thus, if TiO2-NPs could cause vasculature leakiness in the lung, increased 
melanoma colonization in the lung could be expected.  
 
a. Acute exposure study  
In an acute study that spanned for one week, the mice received 10
6
 melanoma cells 
(B16F10) and three high dose boluses of TiO2-NPs via intravenous injection. The mice were 




injected every other day with TiO2-NPs at the dose of 50 and 150 mg/kg BW. At the end of 
the acute study, the mice were sacrificed and melanoma-to-lung metastasis incidence in the 
TiO2-NPs treated groups were observed to be significantly more when compared to the 
vehicle control. 
Superficial observation of the lungs clearly showed the metastasis of melanoma to the 
lungs for all treatment groups, as evidenced by the presence of melanoma colonies occurring 
on the lung tissue that is notable due to their black coloration (Figure 6.2). It is worthy to 
note that there was an increase in the melanoma-to-lung metastasis incidence with increasing 
TiO2-NPs dose (Figure 6.2).  
 
 
Figure 6.2: Superficial observation of the lung shows TiO2-NPs capability to promote in 
vivo endothelial cell leakiness in an acute TiO2-NPs exposure melanoma to lung 
metastasis model. B16F10 cells in circulation were able to establish more colonies (green 
arrowheads) in lungs. There was a dramatic increase in superficial lung metastatic load from 
50 to 150 mg TiO2-NPs/kg BW. Black coloration denotes metastatic colonies. Scale bar: 1 
cm.  
 
Quantitative PCR (qPCR) analysis for Mlana gene that encodes melanin A, the specific 
marker of melanoma cells (Huang et al., 2011) was employed to quantify the metastasis load 
within the lungs. Melanin A expression in the lung tissue for TiO2-NPs treated groups was 
observed to significantly increase when compared to the vehicle control groups (Figure 6.3). 
Melanin A expression level was detected approximately 14-fold and 30-fold higher than the 
control in the lung harvested from mice treated with 50 mg/kg and 150 mg/kg of TiO2-NPs, 




respectively (Figure 6.3). This increase in the melanin A expression that was detected in the 
tissue suggest increase in melanoma with increasing TiO2-NPs dose. This result is in 
agreement with the previous superficial observation that showed the increased melanoma-to-
lung incidences following the increase of  TiO2-NPs dose. 
 
Figure 6.3: qPCR shows TiO2-NPs capability to promote in vivo endothelial cell 
leakiness in an acute TiO2-NPs exposure melanoma to lung metastasis model. qPCR 
analysis of lung tissues showed significant increase in melanin A expression with increasing 
dose of TiO2-NPs treatment. Data are means ± s.d from triplicate qPCR reactions per 
individual lungs (n=3 per group). One way ANOVA with Tukey’s HSD post-hoc test, 
compared to untreated control, *p<0.05. 
 
The cross-section staining of lung tissues corroborated the previous observation. 
Distinct melanoma colonies on the stroma of the lung lobes were clearly observed due to 
their dark coloration (Figure 6.4A). Scoring of histologically stained lung sections showed 
significant increase of tumor penetration and tumor nodule formation with increasing dose of 
TiO2-NPs (Figure 6.4B). Moreover, lung section coverage area quantification shows 
approximately 5.5-fold and 18.3-fold increase of melanoma coverage on the lungs of mice 
treated with 50 mg/kg and 150 mg/kg TiO2-NPs, respectively (Figure 6.4C). Collectively, 
the acute exposure of TiO2-NPs was found to cause dose dependent vasculature leakiness in 








Figure 6.4: Histology analysis of the lung sections shows TiO2-NPs capability to promote 
in vivo endothelial cell leakiness in an acute TiO2-NPs exposure melanoma to lung 
metastasis model. (A) Eosin stained sections of lungs showing melanoma colonies (green 
arrowheads). Scale bar: 50 μm.  (B) Dose dependent increase of cancer infiltration degree. 
Quantification was made through blinded scoring of tumor nodule on the lung sections. The 
blind scoring was done by 10 unbiased evaluators over 6 randomly selected sections per 
group (n=3 lungs per group). Data are means ± s.d. One way ANOVA with Tukey’s HSD 
post-hoc test, compared to untreated control *p<0.05. (C) There was significant increase on 
tumor area of occupancy in the lung sections with the increase dose of TiO2-NPs. One way 
ANOVA with Tukey’s HSD post-hoc test, n= 18 per group, compared to untreated control, 










b. Sub-chronic exposure study 
Though it provides important information on the effect of accumulated TiO2-NPs on the 
vasculature integrity, the TiO2-NPs doses employed in the acute exposure study were 
recognized to be high. This could potentially lead to very low animal survival rates if the 
experimentation was prolonged, making it difficult to study the sub-chronic effect of the 
TiO2-NPs on the vasculature integrity. Hence, to study sub-chronic treatment of TiO2-NPs, 
we dropped the concentration by 30-fold to 5mg/kg and injected a single bolus of 500,000 
cells at the start of the third week.  The TiO2-NPs treatment was extended to the end of 4 
weeks, totaling the treatment of 7 boluses which were given every other day. In addition, 
TiO2-MPs (400 nm) were introduced as another study group. Tumor nodules were observed 
to be present on the surface of the lung for all treatment groups. However, the amounts of 
tumor nodules on the surface of these lung lobes were greatly different between each group. 
The group that received TiO2-NPs (23.5 nm) was observed to have the most number of tumor 
nodules on the lung surface. In stark contrast, the TiO2-MPs (400 nm) treated group did not 
show any significant amount of melanoma colonies on the lung surface when compared to 
control group (Figure 6.5). 
 
 
Figure 6.5: Superficial observation of the lungs shows the capability of TiO2-NPs and 
not TiO2-MPs to promote in vivo endothelial cell leakiness in a sub-chronic TiO2-NPs 
exposure lung metastasis mouse model. Lung images showing a dramatic increase in lung 
metastasis in the TiO2-NPs (TiO2 nano) treated group compared to other groups namely, 
control groups and TiO2-MPs (TiO2 micro) treated groups. Black coloration denotes 
metastatic colonies Scale bar: 1 cm.  





Consistent with our superficial observations of the lungs, qPCR analysis detected 
highest level of melanin A expression in the TiO2-NPs treatment group (Figure 6.6). The 
TiO2-NPs treated group showed more than 19-fold change of melanin A expression, which 
was approximately 6 times higher than the melanin A level detected on the control group 
(Figure 6.6). In contrast, there was no significant increase of melanin A expression in the 
TiO2-MPs treated groups when compared to the control group (Figure 6.6). This suggests 
that TiO2-NPs induced significantly higher melanoma-to-lung metastatic colonization as 
compared with control and the TiO2-MPs groups. 
 
Figure 6.6: qPCR shows the capability of TiO2-NPs and not TiO2-MPs to promote in 
vivo endothelial cell leakiness in a sub-chronic TiO2-NPs exposure lung metastasis 
mouse model.  qPCR analysis of melanoma tumors in lungs shows significant increase of 
melanin A expression with TiO2-NPs (nano) treatment. Data are means ± s.d. from 3 different 
lungs. One way ANOVA with Tukey’s HSD post-hoc test, compared to control,*p<0.05.  
 
 
Distinct melanoma colonies on the stroma of the lung lobes were clearly observed on 
the lung tissues of TiO2-NPs treated group, while the lung tissue from control and TiO2-MPs 
treated groups were relatively clear of melanoma colonization (Figure 6.7A). Scoring of 
histologically stained lung sections showed significant increase of tumor penetration and 
tumor nodule formation in TiO2-NPs groups as compared to the control and TiO2-MPs 




groups (Figure 6.7B). Moreover percentage of lung section coverage by tumors was also 
significantly increased in the group with TiO2-NPs treatment compared to the two other 
groups (Figure 6.7C). Collectively, the sub-chronic exposure of TiO2-NPs was found to 
cause size dependent vasculature leakiness in the in vivo setting, in line with the previously 
described in vitro observation (Figure 4.2-4.4) 
 
 
Figure 6.7: Histology analysis of lung sections shows the capability of TiO2-NPs and not 
TiO2-MPs to promote in vivo endothelial cell leakiness in a sub-chronic TiO2-NPs 
exposure lung metastasis mouse model.   (A) Eosin stained sections of lungs of mice. 
Tumor nodule (Tu) indicated the presence of metastasized melanoma in the lung stroma. 
Scale bar: 50 μm. (B) Size dependent increase of cancer infiltration degree. Quantification 
was made through blinded scoring of tumor nodule on the lung sections. The blind scoring 
was done by 10 unbiased evaluators over 6 randomly selected sections per group (n=3 lungs 
per group). Data are means ± s.d., One way ANOVA with Tukey’s HSD post-hoc test, 
compared to untreated control, *p<0.05. (C) There was significantly higher area occupancy 
of tumors in the lung sections of the TiO2-NPs treated animals as compared to the control and 
TiO2-MPs treated groups. One way ANOVA with Tukey’s HSD post-hoc test, n= 18 per 
group, compared to untreated control, *p<0.05.  
 
 





It was recognized that these animal studies are proof-of-concept experiments that do not 
fully indicate real human situations.  However, it is worth to note that such controlled animal 
experiments are needed to fully understand the risk of NMs. To date, there are no published 
studies involving controlled human exposures of TiO2-NPs over a long period of time. As 
such, there is no quantification data of TiO2-NPs accumulation in major human organs. 
Mouse studies employing TiO2-NPs inhalation and dermal introduction, however, showed a 
low percentage of these NPs traversing the various barriers and accumulating in the various 
major organs (Geiser and Kreyling, 2010; Wu et al., 2010b). Study on engineered TiO2-NPs 
occupational inhalation discovered that the NPs biopersist in the lung due to low clearance 
rate (Oberdorster et al., 1997). Surmising from these reports, it could be assumed that with 
ample time, dose and frequency of exposure, TiO2-NPs accumulation in the lung could reach 
the NanoEL inducing dose. Moreover, pre-existing conditions (e.g. infection) that increase 
vascular permeability could exacerbate the effect of TiO2-NPs exposure and induction of 
NanoEL (Xu et al., 2008).  
Injection as mode of delivery of TiO2-NPs in this mouse experiment is acknowledged to 
be artificial, due to the rarity of intentional TiO2-NPs introduction into the bloodstream with 
exception of nanomedicine. This suggests the need to consider the possibility where 
nanomedicine, introduced into vascular system, becomes counterproductive due to the 
unintentional induction of vascular leakiness. The unintentional induction of vascular 
leakiness could potentially lead to the accumulation of the nanomedicine in major organs, 
rather than the intentioned target site. Moreover, in case of tumor treatment, the unintentional 
induction of vascular leakiness by nanomedicine could enhance secondary metastasis through 
the NanoEL effect, as observed in this study. 
 





In summary, this study has demonstrated that NanoEL could also occur in the complex 
in vivo setting. The TiO2-NPs induce vascular leakiness was observed in two different mouse 
models of subcutaneous delivery and melanoma metastasis. Consistent with the in vitro 
study, the in vivo data indicate that TiO2-NPs induced vasculature leakiness depends on both 














This chapter summarizes the major findings with regards to the study of the interaction 
between NMs and endothelial cells. The major conclusions of this work are itemized under 
the three components of (1) in vitro evidence of interaction between TiO2-NPs with 
microvascular endothelial cell monolayer and its effect on regulation of monolayer 
permeability, (2) the mechanism underlying the said interaction, and (3) the in vivo validation 
of TiO2-NPs interaction with microvascular endothelial cells. The significance of this study is 




In the effort to investigate the potential effect of nanomaterials on endothelial cells of 
blood vessel, NPs over a short exposure time (30 minutes) were found to induce the 
formation of intercellular gaps on a confluent monolayer of endothelial cells. This effect, 
coined as NanoEL, was direct evidence that NMs could interact with endothelial cells and 
potentially perturb their main role as a selective gatekeeper of molecule transport. NanoEL 
was induced in a dose dependent manner by NPs but not by their MPs counterpart, suggesting 
that the size of materials determines the occurrence of the event. This highlights the 
importance of understanding the NMs physicochemical information in its safety assessment. 
Moreover, there were no perceivable cytotoxicity and oxidative stress accompanying the 
NanoEL. Though these findings are in sharp contrast with typical nano-bio interaction 
studies, they serve to highlight the necessity to revamp the current practices in assessing 
nanosafety and expand the cell health indicator beyond the traditional cytotoxicity and 
oxidative stress readouts. 
A mechanistic study was conducted in order to shed light on the mechanism that triggers 
the NanoEL occurrence. NanoEL was found to be initiated through the direct binding of 




TiO2-NPs with VE-cadherin, an AJ protein that is indispensable in the maintenance of 
endothelial cell barrier integrity, causing disruption of the VE-cadherin clusters. As an 
outcome of this disruption on VE-cadherin clusters, a cascade of non-receptor mediated 
mechanism was triggered, wherein the VE-cadherin was phosphorylated at its two important 
residues, Y658 and Y731. The phosphorylation of these residues results in two-prong events, 
VE-cadherin internalization and degradation, and actin remodeling. The former is triggered 
by the loss of interaction between VE-cadherin and p120 due to phosphorylation at Y658 
residue. The latter is activated by actin filament untethering following the loss of VE-
cadherin and β-catenin interaction due to phosphorylation at Y731 residue. These two-prong 
events result in changes in cell shape and the formation of intercellular gaps between 
endothelial cells. The proposed mechanism of NMs induced endothelial cells leakiness is 
depicted in Figure 7.1. 
Though the NMs induced leakiness on endothelial cell barrier has been previously 
reported, the mechanism reported in this study is of a crucial importance. It is also for the 
first time in that physical interaction between NMs and endothelial cells is described to 
trigger leakiness in endothelium barrier without activating the receptor-mediated pathway or 
evoking the ROS canonical signaling. 
The relevance of this phenomenon in physiological condition was investigated with the 
mouse model.  In vivo results decidedly showed that TiO2-NPs induced leakiness in the blood 
vessel, as observed by the increased flux of Evans blue dye extravasating out from the blood 
circulation to the skin tissue. Furthermore, mice treated with TiO2-NPs both acutely and 
chronically were observed to have higher melanoma-lung metastasis when compared to the 
control group. The higher cancer metastasis can be attributed to the fact that TiO2-NPs 
induced blood vessel leakiness in the mouse model, facilitating cancer extravasation from the 
blood vessel and cancer metastasis into lung, similar to what was observed for the leakiness 




promoting compounds, ANGPTL-4 or VEGF. These results suggest that endothelial cell 
barrier leakiness could increase the risk factor for certain pathologies (e.g. cancer, diabetes 
and cardiovascular disease) as its presence could potentially increase the progression of these 
diseases.  
Overall, the study offers evidence and explanation to the fundamental question on how 
NMs interaction with cellular entities could lead to damaging effects on a biological system. 
This understanding is important as it enables material scientists to re-design the 
nanomaterials to negate their adverse effects, specifically to endothelial cell barrier. In 
addition, the study has provided a new perspective on nano-bio interaction where physical 
interaction between nanomaterials and cells, and not the canonical signaling pathway, drives 
the observed nanotoxicity. It is interesting to note that the fundamental understanding 
garnered from this study could potentially be applied to better design of NMs by enhancing 
their capability to cross over resistive barriers (e.g. blood brain barrier) and in turn enabling 
them to effectively deliver drug cargo. 
 
 





Figure 7.1: Proposed mechanism of TiO2-NPs induced endothelial leakiness (NanoEL). 
(A) The anatomy of a normal AJ. Intact monolayer of connected endothelial cells is 
maintained by stable VE-cadherin homophilic interactions with neighbouring cells. VE-
cadherin forms a trans-homophillic interaction at the EC domains with another cis-paired 
VE-cadherin complex. β-catenin, p120 and VE-cadherin form a complex through their 
binding to intracellular domain of VE-cadherin. Formation of this ternary complex stabilizes 
the AJ (Drees et al., 2005). Distance of AJ is at least 22.5 nm. (B) TiO2-NPs are small enough 
to migrate into the AJ; they bind and disrupt VE-cadherin homophilic interaction (1). This 
disruption induces the phosphorylation of Y658 of VE-cadherin via a currently unknown 
kinase pathway, while the Y731 residue is phosphorylated by Src kinase. The 
phosphorylation at the two residues induces the loss of interaction between VE-cadherin, β-
catenin and p120 (2). The loss of interaction of the VE-cadherin-β-catenin-p120 complex 
destabilizes actin and leads to actin remodeling (3) as a result the cell retracts and leakiness 
occurs (4). After TiO2-NPs binding to VE-cadherin, VE-cadherin might be internalized and 
further degraded by lysosomes. Phosphorylation of VE-cadherin due to NanoEL may result 
in internalization and lysosomal degradation. This minimizes the overall amounts of VE-
cadherin near the vicinity of the cell membrane. TiO2-NPs might be internalized alongside 
VE-cadherin as it remained bound to VE-cadherin but the final fate of the TiO2-NPs is 
uncertain.  




7.2. Future Perspectives 
Though size of materials was shown to be a decisive factor in inducing a dysfunctional 
endothelial cell barrier, it is worthy to note that this study only utilized two sizes of TiO2-NPs 
(i.e. 25 nm and 400 nm). Thus, it would be worthwhile to extend this study to provide a larger 
library of TiO2-NPs with varying sizes. Moreover, due to time limitation, other 
physicochemical parameters of TiO2-NPs such as charge, density and ligand coating are 
beyond the scope of this study. As these parameters play a primary role in deciding any 
biological outcome, future study is needed to investigate the effect of these parameters on 
endothelial cell barrier integrity.  
Though different in their specific forms and functions, most barriers in the human body 
share a commonality in the form of a family of protein, the cadherins, which is responsible 
for the formation of these barriers. Therefore, it would be of a great interest to study whether 
the nanomaterial-induced barrier dysfunction observed in this study could happen beyond the 
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Figure A1.1: Characterization of TiO2-MPs. (A) Transmission electron microscope (TEM) 
micrograph of TiO2-MPs. Scale bar = 500 nm. (B) Summary of hydrodynamic properties of 





































Figure A1.2: TiO2-NPs induced in vitro endothelial cells leakiness within 30 minutes of exposure. Various concentrations of TiO2-NPs 
induced the disruption on the endothelial cell barrier integrity (red arrowheads) within short exposure time of 30 minutes. Visualization was 
done with immunofluorescence whereby AJ protein, VE-cadherin, were visualized in green and the cells nuclei in blue. Scale bar: 50 µm.  






Figure A1.3: TiO2-NPs induced in vitro endothelial cells leakiness within 60 minutes of exposure. Various concentrations of TiO2-NPs 
induced the disruption on the endothelial cell barrier integrity (red arrowheads) was persisted even after 60 minutes of exposure. Visualization 
was done with immunofluorescence whereby AJ protein, VE-cadherin, were visualized in green and the cells nuclei in blue. Scale bar: 50 µm.  





Figure A1.4: TiO2-MPs did not induce in vitro endothelial cells leakiness. No disruption of endothelial cell monolayer barrier was observed 
60 minutes after the introduction of TiO2-MPs in various concentrations. Visualization was done with immunofluorescence whereby AJ protein, 
VE-cadherin, were visualized in green and the cells nuclei in blue. Scale bar: 50 µm.  
 










Figure A1.5: Negative control of immunofluorescence experiment. AJ protein, VE-cadherin only can be visualized when the primary 
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